activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1704011	CHEMBL861202	Inhibitory activity against EphB3	B	COc1ccc(N2Cc3cnc(Nc4ccc(F)cc4)nc3N([C@@H]3CC[C@@H](O)C3)C2=O)cc1		CHEMBL606964	=	IC50	nM	1250.0	CHEMBL4901	Homo sapiens	IC50	nM	1250.0
	1704011	CHEMBL861202	Inhibitory activity against EphB3	B	COc1ccc(N2Cc3cnc(Nc4ccc(F)cc4)nc3N([C@@H]3CC[C@@H](O)C3)C2=O)cc1		CHEMBL606964	=	IC50	nM	1250.0	CHEMBL4901	Homo sapiens	IC50	nM	1250.0
	1777531	CHEMBL908837	Inhibition of EPHB3	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Ki	nM	5000.0	CHEMBL4901	Homo sapiens	Ki	uM	5.0
	1960637	CHEMBL892539	Inhibition of EPHB3	B	NC1=NC(=O)/C(=C/c2ccc3ncccc3c2)S1		CHEMBL396377	>	Ki	nM	2000.0	CHEMBL4901	Homo sapiens	Ki	uM	2.0
	1960638	CHEMBL892539	Inhibition of EPHB3	B	O=C1N=C(N[C@@H]2C[C@H]2c2ccccc2)S/C1=C\c1ccc2ncccc2c1		CHEMBL235345	>	Ki	nM	2000.0	CHEMBL4901	Homo sapiens	Ki	uM	2.0
	1960639	CHEMBL892539	Inhibition of EPHB3	B	O=C1N=C(NCc2cccs2)S/C1=C\c1ccc2ncccc2c1		CHEMBL393929	>	Ki	nM	2000.0	CHEMBL4901	Homo sapiens	Ki	uM	2.0
	2137313	CHEMBL936795	Inhibition of EphB3	B	O=C1N=C(NCc2cccs2)S/C1=C/c1ccc2ncccc2c1		CHEMBL261644	>	Ki	nM	2000.0	CHEMBL4901	Homo sapiens	Ki	nM	2000.0
	2147255	CHEMBL921845	Activity of human EphB3 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	95.0	CHEMBL4901	Homo sapiens	Activity	%	95.0
	2470178	CHEMBL1034127	Inhibition of EPHB3 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4901	Homo sapiens	INH	%	10.0
Not Evaluated	2476662	CHEMBL1024914	Binding affinity to human EPHB3 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL4901	Homo sapiens	Activity		
Not Evaluated	2476865	CHEMBL1024914	Binding affinity to human EPHB3 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4901	Homo sapiens	Activity		
Not Evaluated	2478704	CHEMBL1024914	Binding affinity to human EPHB3 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4901	Homo sapiens	Activity		
	2479543	CHEMBL988937	Binding affinity to human EPHB3	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Kd	nM	81.0	CHEMBL4901	Homo sapiens	Kd	nM	81.0
Not Evaluated	2479762	CHEMBL1024914	Binding affinity to human EPHB3 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL4901	Homo sapiens	Activity		
Not Evaluated	2480559	CHEMBL1024914	Binding affinity to human EPHB3 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL4901	Homo sapiens	Activity		
	2480761	CHEMBL1024914	Binding affinity to human EPHB3 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	7.2	CHEMBL4901	Homo sapiens	Activity	%	7.2
Not Evaluated	2577383	CHEMBL1024914	Binding affinity to human EPHB3 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL4901	Homo sapiens	Activity		
Not Evaluated	2593588	CHEMBL1024914	Binding affinity to human EPHB3 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL4901	Homo sapiens	Activity		
Active	2593791	CHEMBL1024914	Binding affinity to human EPHB3 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL4901	Homo sapiens	Activity		
Not Evaluated	2593854	CHEMBL1024914	Binding affinity to human EPHB3 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL4901	Homo sapiens	Activity		
Not Evaluated	2594057	CHEMBL1024914	Binding affinity to human EPHB3 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL4901	Homo sapiens	Activity		
Not Evaluated	2595000	CHEMBL1024914	Binding affinity to human EPHB3 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4901	Homo sapiens	Activity		
Not Evaluated	2595269	CHEMBL1024914	Binding affinity to human EPHB3 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4901	Homo sapiens	Activity		
Not Evaluated	2596197	CHEMBL1024914	Binding affinity to human EPHB3 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4901	Homo sapiens	Activity		
Not Evaluated	2596400	CHEMBL1024914	Binding affinity to human EPHB3 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL4901	Homo sapiens	Activity		
Not Evaluated	2597669	CHEMBL1024914	Binding affinity to human EPHB3 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL4901	Homo sapiens	Activity		
Not Evaluated	2597872	CHEMBL1024914	Binding affinity to human EPHB3 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4901	Homo sapiens	Activity		
	2619058	CHEMBL1035829	Inhibition of human EphB3 by IMAP assay	B	C=CCc1c(C)nc2sc3c(N)ncnc3c2c1C		CHEMBL463119	>	Ki	nM	5000.0	CHEMBL4901	Homo sapiens	Ki	nM	5000.0
Active	2719542	CHEMBL1059992	Inhibition of EphB3 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4cncc(-c5cccs5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL556140		Inhibition	%		CHEMBL4901	Homo sapiens	INH		
	2721602	CHEMBL1057430	Inhibition of EphB3 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
	2905952	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	1400.0	CHEMBL4901	Homo sapiens	Kd	nM	1400.0
	2905953	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905954	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905955	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905956	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905957	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905958	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905959	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905960	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905961	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905962	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905963	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	6.9	CHEMBL4901	Homo sapiens	Kd	nM	6.9
	2905964	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905965	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905966	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905967	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905968	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905969	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905970	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905971	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905972	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905973	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905974	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905975	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	3500.0	CHEMBL4901	Homo sapiens	Kd	nM	3500.0
	2905976	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905977	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905978	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905979	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905980	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905981	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905982	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905983	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905984	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905985	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905986	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905987	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905988	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2905989	CHEMBL1061070	Binding constant for EPHB3 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	2921350	CHEMBL1053715	Inhibition of EPHB3 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	10.0	CHEMBL4901	Homo sapiens	Activity	%	10.0
	2926260	CHEMBL1056933	Inhibition of EPHB3 assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	28.0	CHEMBL4901	Homo sapiens	Activity	%	28.0
	2928446	CHEMBL1048227	Inhibition of EPHB3 assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	3.0	CHEMBL4901	Homo sapiens	Activity	%	3.0
	2928508	CHEMBL1046779	Inhibition of EphB3 by [gamma33-P]ATP based assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	IC50	nM	15.0	CHEMBL4901	Homo sapiens	IC50	nM	15.0
	2999919	CHEMBL1041100	Inhibition of EPHB3 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	94.0	CHEMBL4901	Homo sapiens	Activity	%	94.0
	2999995	CHEMBL1041100	Inhibition of EPHB3 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	95.0	CHEMBL4901	Homo sapiens	Activity	%	95.0
	3052600	CHEMBL1037576	Residual activity of EPHB3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	106.0	CHEMBL4901	Homo sapiens	Residual activity	%	106.0
	3053909	CHEMBL1044309	Residual activity of EPHB3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	105.0	CHEMBL4901	Homo sapiens	Residual activity	%	105.0
	3054161	CHEMBL1040629	Residual activity of EPHB3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	112.0	CHEMBL4901	Homo sapiens	Residual activity	%	112.0
	3055448	CHEMBL1037576	Residual activity of EPHB3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	108.0	CHEMBL4901	Homo sapiens	Residual activity	%	108.0
	3055700	CHEMBL1044309	Residual activity of EPHB3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	372.0	CHEMBL4901	Homo sapiens	Residual activity	%	372.0
	3057005	CHEMBL1040629	Residual activity of EPHB3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	102.0	CHEMBL4901	Homo sapiens	Residual activity	%	102.0
	3058325	CHEMBL1037576	Residual activity of EPHB3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	105.0	CHEMBL4901	Homo sapiens	Residual activity	%	105.0
	3058577	CHEMBL1044309	Residual activity of EPHB3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	227.0	CHEMBL4901	Homo sapiens	Residual activity	%	227.0
	3072923	CHEMBL1040629	Residual activity of EPHB3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	117.0	CHEMBL4901	Homo sapiens	Residual activity	%	117.0
	3213805	CHEMBL1108392	Inhibition of EPHB3 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	101.0	CHEMBL4901	Homo sapiens	INH	%	101.0
Active	3214066	CHEMBL1107579	Inhibition of ephrin-B3-stimulated human recombinant EphB3 receptor autophosphorylation expressed in HEK293 cells at 10 uM treated 30 mins before ephrinB3 challenge measured after 30 mins by immunoprecipitation	B	O=C(Nc1ccccc1Cl)c1cnn2ccccc12		CHEMBL1078785		Activity			CHEMBL4901	Homo sapiens	Activity		
Not Active	3214067	CHEMBL1107579	Inhibition of ephrin-B3-stimulated human recombinant EphB3 receptor autophosphorylation expressed in HEK293 cells at 10 uM treated 30 mins before ephrinB3 challenge measured after 30 mins by immunoprecipitation	B	O=C(Nc1ccccc1)c1cnn2ccccc12		CHEMBL1077476		Activity			CHEMBL4901	Homo sapiens	Activity		
Not Active	3215133	CHEMBL1107579	Inhibition of ephrin-B3-stimulated human recombinant EphB3 receptor autophosphorylation expressed in HEK293 cells at 10 uM treated 30 mins before ephrinB3 challenge measured after 30 mins by immunoprecipitation	B	O=C(Nc1ccccc1F)c1cnn2ccccc12		CHEMBL1078965		Activity			CHEMBL4901	Homo sapiens	Activity		
Not Active	3215134	CHEMBL1107579	Inhibition of ephrin-B3-stimulated human recombinant EphB3 receptor autophosphorylation expressed in HEK293 cells at 10 uM treated 30 mins before ephrinB3 challenge measured after 30 mins by immunoprecipitation	B	O=C(Nc1ccc(Cl)cc1)c1cnn2ccccc12		CHEMBL1078885		Activity			CHEMBL4901	Homo sapiens	Activity		
Not Active	3215135	CHEMBL1107579	Inhibition of ephrin-B3-stimulated human recombinant EphB3 receptor autophosphorylation expressed in HEK293 cells at 10 uM treated 30 mins before ephrinB3 challenge measured after 30 mins by immunoprecipitation	B	Cn1cc(C(=O)Nc2ccccc2Cl)c2ccccc21		CHEMBL1078145		Activity			CHEMBL4901	Homo sapiens	Activity		
Active	3215136	CHEMBL1107579	Inhibition of ephrin-B3-stimulated human recombinant EphB3 receptor autophosphorylation expressed in HEK293 cells at 10 uM treated 30 mins before ephrinB3 challenge measured after 30 mins by immunoprecipitation	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739		Activity			CHEMBL4901	Homo sapiens	Activity		
Active	3215137	CHEMBL1107579	Inhibition of ephrin-B3-stimulated human recombinant EphB3 receptor autophosphorylation expressed in HEK293 cells at 10 uM treated 30 mins before ephrinB3 challenge measured after 30 mins by immunoprecipitation	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3(O)CCNCC3)cn12		CHEMBL1077740		Activity			CHEMBL4901	Homo sapiens	Activity		
Active	3215138	CHEMBL1107579	Inhibition of ephrin-B3-stimulated human recombinant EphB3 receptor autophosphorylation expressed in HEK293 cells at 10 uM treated 30 mins before ephrinB3 challenge measured after 30 mins by immunoprecipitation	B	O=C(Nc1ccccc1Cl)c1cnn2ccc(N3CCCCC3)cc12		CHEMBL1078214		Activity			CHEMBL4901	Homo sapiens	Activity		
Active	3215139	CHEMBL1107579	Inhibition of ephrin-B3-stimulated human recombinant EphB3 receptor autophosphorylation expressed in HEK293 cells at 10 uM treated 30 mins before ephrinB3 challenge measured after 30 mins by immunoprecipitation	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(N3CCCCC3)cn12		CHEMBL1078840		Activity			CHEMBL4901	Homo sapiens	Activity		
	3215140	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1cnn2ccccc12		CHEMBL1078785	=	IC50	nM	1000.0	CHEMBL4901	Homo sapiens	IC50	uM	1.0
	3215141	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1ccccc1F)c1cnn2ccccc12		CHEMBL1078965	=	IC50	nM	20000.0	CHEMBL4901	Homo sapiens	IC50	uM	20.0
	3215142	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1cccc(Cl)c1Cl)c1cnn2ccccc12		CHEMBL1079075	=	IC50	nM	20000.0	CHEMBL4901	Homo sapiens	IC50	uM	20.0
	3215143	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1ccccc1C(F)(F)F)c1cnn2ccccc12		CHEMBL1078902	=	IC50	nM	20000.0	CHEMBL4901	Homo sapiens	IC50	uM	20.0
	3215144	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	N#Cc1ccccc1NC(=O)c1cnn2ccccc12		CHEMBL1077512	=	IC50	nM	20000.0	CHEMBL4901	Homo sapiens	IC50	uM	20.0
	3215145	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1cnn2ccccc12)c1ccccc1Cl		CHEMBL1080221	=	IC50	nM	20000.0	CHEMBL4901	Homo sapiens	IC50	uM	20.0
	3215146	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	Clc1ccccc1NCc1cnn2ccccc12		CHEMBL1080222	=	IC50	nM	20000.0	CHEMBL4901	Homo sapiens	IC50	uM	20.0
	3215147	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	Cc1cccn2ncc(C(=O)Nc3ccccc3Cl)c12		CHEMBL1080223	=	IC50	nM	15000.0	CHEMBL4901	Homo sapiens	IC50	uM	15.0
	3215148	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	Cc1ccn2ncc(C(=O)Nc3ccccc3Cl)c2c1		CHEMBL1081498	=	IC50	nM	260.0	CHEMBL4901	Homo sapiens	IC50	uM	0.26
	3215149	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	Cc1ccc2c(C(=O)Nc3ccccc3Cl)cnn2c1		CHEMBL1081499	=	IC50	nM	15000.0	CHEMBL4901	Homo sapiens	IC50	uM	15.0
	3215150	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1cnn2cccc(Cl)c12		CHEMBL1080956	=	IC50	nM	20000.0	CHEMBL4901	Homo sapiens	IC50	uM	20.0
	3215151	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1cnn2ccc(Cl)cc12		CHEMBL1080957	=	IC50	nM	2000.0	CHEMBL4901	Homo sapiens	IC50	uM	2.0
	3215152	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1cnn2cc(Cl)ccc12		CHEMBL1080958	=	IC50	nM	20000.0	CHEMBL4901	Homo sapiens	IC50	uM	20.0
	3215153	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	COc1ccn2ncc(C(=O)Nc3ccccc3Cl)c2c1		CHEMBL1080959	=	IC50	nM	190.0	CHEMBL4901	Homo sapiens	IC50	uM	0.19
	3215154	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1cnn2ccc(-c3ccccc3)cc12		CHEMBL1078107	=	IC50	nM	66.0	CHEMBL4901	Homo sapiens	IC50	uM	0.066
	3215155	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	CN(C)c1ccn2ncc(C(=O)Nc3ccccc3Cl)c2c1		CHEMBL1077571	=	IC50	nM	77.0	CHEMBL4901	Homo sapiens	IC50	uM	0.077
	3215156	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1cnn2ccc(-n3cccc3)cc12		CHEMBL1078108	=	IC50	nM	200.0	CHEMBL4901	Homo sapiens	IC50	uM	0.2
	3215157	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1cnn2ccc(N3CCOCC3)cc12		CHEMBL1078109	=	IC50	nM	240.0	CHEMBL4901	Homo sapiens	IC50	uM	0.24
	3215158	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1cnn2ccc(N3CCCCC3)cc12		CHEMBL1078214	=	IC50	nM	63.0	CHEMBL4901	Homo sapiens	IC50	uM	0.063
	3215159	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1cnn2ccc(OCc3ccccc3)cc12		CHEMBL1078726	=	IC50	nM	20000.0	CHEMBL4901	Homo sapiens	IC50	uM	20.0
	3215160	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1n[nH]c2ccccc12		CHEMBL1078238	=	IC50	nM	20000.0	CHEMBL4901	Homo sapiens	IC50	uM	20.0
	3215161	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1nnn2ccccc12		CHEMBL1078239	=	IC50	nM	20000.0	CHEMBL4901	Homo sapiens	IC50	uM	20.0
	3215162	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1cnn2ccncc12		CHEMBL1077850	=	IC50	nM	15000.0	CHEMBL4901	Homo sapiens	IC50	uM	15.0
	3215163	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1cnc2ccccn12		CHEMBL1078738	=	IC50	nM	460.0	CHEMBL4901	Homo sapiens	IC50	uM	0.46
	3215164	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(-c3ccccc3)cn12		CHEMBL1078739	=	IC50	nM	60.0	CHEMBL4901	Homo sapiens	IC50	uM	0.06
	3215165	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(N3CCCCC3)cn12		CHEMBL1078840	=	IC50	nM	87.0	CHEMBL4901	Homo sapiens	IC50	uM	0.087
	3215166	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	COc1ccccc1NC(=O)c1cnc2ccc(-c3ccccc3)cn12		CHEMBL1078542	=	IC50	nM	20000.0	CHEMBL4901	Homo sapiens	IC50	uM	20.0
	3215167	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	Cc1nc2ccc(-c3ccccc3)cn2c1C(=O)Nc1ccccc1Cl		CHEMBL1077738	=	IC50	nM	20000.0	CHEMBL4901	Homo sapiens	IC50	uM	20.0
	3215168	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	IC50	nM	79.0	CHEMBL4901	Homo sapiens	IC50	uM	0.079
	3215169	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3(O)CCNCC3)cn12		CHEMBL1077740	=	IC50	nM	228.0	CHEMBL4901	Homo sapiens	IC50	uM	0.228
Not Active	3215170	CHEMBL1107576	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation at 20 uM after 30 mins by scintillation counting	B	O=C(Nc1ccccc1)c1cnn2ccccc12		CHEMBL1077476		IC50			CHEMBL4901	Homo sapiens	IC50		
Not Active	3215171	CHEMBL1107576	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation at 20 uM after 30 mins by scintillation counting	B	O=C(Nc1cccc(Cl)c1)c1cnn2ccccc12		CHEMBL1078966		IC50			CHEMBL4901	Homo sapiens	IC50		
Not Active	3215172	CHEMBL1107576	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation at 20 uM after 30 mins by scintillation counting	B	O=C(Nc1ccc(Cl)cc1)c1cnn2ccccc12		CHEMBL1078885		IC50			CHEMBL4901	Homo sapiens	IC50		
Not Active	3215173	CHEMBL1107576	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation at 20 uM after 30 mins by scintillation counting	B	COc1ccccc1NC(=O)c1cnn2ccccc12		CHEMBL1078901		IC50			CHEMBL4901	Homo sapiens	IC50		
Not Active	3215174	CHEMBL1107576	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation at 20 uM after 30 mins by scintillation counting	B	CS(=O)(=O)c1ccccc1NC(=O)c1cnn2ccccc12		CHEMBL1080048		IC50			CHEMBL4901	Homo sapiens	IC50		
Not Active	3215175	CHEMBL1107576	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation at 20 uM after 30 mins by scintillation counting	B	CN(C(=O)c1cnn2ccccc12)c1ccccc1Cl		CHEMBL1080049		IC50			CHEMBL4901	Homo sapiens	IC50		
Not Active	3215176	CHEMBL1107576	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation at 20 uM after 30 mins by scintillation counting	B	O=C(NCc1ccccc1Cl)c1cnn2ccccc12		CHEMBL1080050		IC50			CHEMBL4901	Homo sapiens	IC50		
Not Active	3215177	CHEMBL1107576	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation at 20 uM after 30 mins by scintillation counting	B	Cc1cccc2c(C(=O)Nc3ccccc3Cl)cnn12		CHEMBL1081500		IC50			CHEMBL4901	Homo sapiens	IC50		
Not Active	3215178	CHEMBL1107576	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation at 20 uM after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1c[nH]c2ccccc12		CHEMBL1077587		IC50			CHEMBL4901	Homo sapiens	IC50		
Not Active	3215179	CHEMBL1107576	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation at 20 uM after 30 mins by scintillation counting	B	Cn1cc(C(=O)Nc2ccccc2Cl)c2ccccc21		CHEMBL1078145		IC50			CHEMBL4901	Homo sapiens	IC50		
Not Active	3215180	CHEMBL1107576	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation at 20 uM after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1ccnc2ccccc12		CHEMBL1078236		IC50			CHEMBL4901	Homo sapiens	IC50		
Not Active	3215181	CHEMBL1107576	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation at 20 uM after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1noc2ccccc12		CHEMBL1078237		IC50			CHEMBL4901	Homo sapiens	IC50		
Not Active	3215182	CHEMBL1107576	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation at 20 uM after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1cnn2cccnc12		CHEMBL1075638		IC50			CHEMBL4901	Homo sapiens	IC50		
Not Active	3215183	CHEMBL1107576	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation at 20 uM after 30 mins by scintillation counting	B	O=C(Nc1ccccc1Cl)c1cnn2ncccc12		CHEMBL1078737		IC50			CHEMBL4901	Homo sapiens	IC50		
	3215198	CHEMBL1107575	Inhibition of human recombinant EphB3 kinase-mediated BTK-peptide phosphorylation assessed as 33P incorporation after 30 mins by scintillation counting	B	Cc1nc2ccc(Br)cn2c1C(=O)Nc1ccccc1Cl		CHEMBL1077741	=	IC50	nM	173.0	CHEMBL4901	Homo sapiens	IC50	uM	0.173
	3224813	CHEMBL1099650	Inhibition of EPHB3 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
	3225063	CHEMBL1099650	Inhibition of EPHB3 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
	3261339	CHEMBL1108058	Inhibition of EPH-B3 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	5.0	CHEMBL4901	Homo sapiens	Activity	%	5.0
	3261363	CHEMBL1108058	Inhibition of EPH-B3 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	17.0	CHEMBL4901	Homo sapiens	Activity	%	17.0
	3331925	CHEMBL1169215	Inhibition of EPHB3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
	3333340	CHEMBL1169215	Inhibition of EPHB3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
	3334745	CHEMBL1169215	Inhibition of EPHB3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
	3336165	CHEMBL1169215	Inhibition of EPHB3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
	3337520	CHEMBL1169215	Inhibition of EPHB3 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
	3337769	CHEMBL1169215	Inhibition of EPHB3 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
	3339103	CHEMBL1169215	Inhibition of EPHB3 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
	3340405	CHEMBL1169215	Inhibition of EPHB3 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
	3340693	CHEMBL1169215	Inhibition of EPHB3 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
	3342109	CHEMBL1169215	Inhibition of EPHB3 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
	3358560	CHEMBL1174405	Inhibition of EPHB3 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.25	CHEMBL4901	Homo sapiens	INH	%	0.25
	3359002	CHEMBL1174405	Inhibition of EPHB3 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	2.7	CHEMBL4901	Homo sapiens	INH	%	2.7
	3443390	CHEMBL1244423	Inhibition of EPHB3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	80.0	CHEMBL4901	Homo sapiens	INH	%	80.0
	3443607	CHEMBL1244423	Inhibition of EPHB3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	78.0	CHEMBL4901	Homo sapiens	INH	%	78.0
	3444762	CHEMBL1244423	Inhibition of EPHB3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	51.0	CHEMBL4901	Homo sapiens	INH	%	51.0
	3445386	CHEMBL1244423	Inhibition of EPHB3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	27.0	CHEMBL4901	Homo sapiens	INH	%	27.0
	3445603	CHEMBL1244423	Inhibition of EPHB3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	19.0	CHEMBL4901	Homo sapiens	INH	%	19.0
	3445812	CHEMBL1244423	Inhibition of EPHB3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	91.0	CHEMBL4901	Homo sapiens	INH	%	91.0
	3446002	CHEMBL1244423	Inhibition of EPHB3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	46.0	CHEMBL4901	Homo sapiens	INH	%	46.0
	3448419	CHEMBL1244822	Binding affinity to EPHB3	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	3448744	CHEMBL1244822	Binding affinity to EPHB3	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	3449655	CHEMBL1244822	Binding affinity to EPHB3	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	3449927	CHEMBL1244822	Binding affinity to EPHB3	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	3450069	CHEMBL1244822	Binding affinity to EPHB3	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	3450331	CHEMBL1244822	Binding affinity to EPHB3	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	3450987	CHEMBL1244822	Binding affinity to EPHB3	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	uM	10.0
	3463223	CHEMBL1252411	Inhibition of EPHB3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	2.0	CHEMBL4901	Homo sapiens	INH	%	2.0
	3463442	CHEMBL1252411	Inhibition of EPHB3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	13.0	CHEMBL4901	Homo sapiens	INH	%	13.0
	3463986	CHEMBL1252411	Inhibition of EPHB3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	10.0	CHEMBL4901	Homo sapiens	INH	%	10.0
	5120338	CHEMBL1645956	Inhibition of human EphB3 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	102.0	CHEMBL4901	Homo sapiens	INH	%	102.0
	5132594	CHEMBL1645816	Inhibition of EPHB3 assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	95.0	CHEMBL4901	Homo sapiens	Activity	%	95.0
	5133737	CHEMBL1645816	Inhibition of EPHB3 assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	100.0	CHEMBL4901	Homo sapiens	Activity	%	100.0
	5133934	CHEMBL1645816	Inhibition of EPHB3 assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	90.0	CHEMBL4901	Homo sapiens	Activity	%	90.0
	5191473	CHEMBL1664093	Inhibition of EPH-B3 at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	12.0	CHEMBL4901	Homo sapiens	INH	%	12.0
	5191474	CHEMBL1664093	Inhibition of EPH-B3 at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	30.0	CHEMBL4901	Homo sapiens	INH	%	30.0
	5243700	CHEMBL1685663	Inhibition of EphB3 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	127.0	CHEMBL4901	Homo sapiens	INH	%	127.0
	5243808	CHEMBL1685912	Inhibition of EphB3 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	119.0	CHEMBL4901	Homo sapiens	INH	%	119.0
	5243921	CHEMBL1685663	Inhibition of EphB3 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	83.0	CHEMBL4901	Homo sapiens	INH	%	83.0
	5244029	CHEMBL1685912	Inhibition of EphB3 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	105.0	CHEMBL4901	Homo sapiens	INH	%	105.0
	5244902	CHEMBL1685663	Inhibition of EphB3 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	96.0	CHEMBL4901	Homo sapiens	INH	%	96.0
	5245010	CHEMBL1685912	Inhibition of EphB3 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	101.0	CHEMBL4901	Homo sapiens	INH	%	101.0
	5245161	CHEMBL1685663	Inhibition of EphB3 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	123.0	CHEMBL4901	Homo sapiens	INH	%	123.0
	5245991	CHEMBL1685912	Inhibition of EphB3 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	131.0	CHEMBL4901	Homo sapiens	INH	%	131.0
	6204512	CHEMBL1781441	Inhibition of EPHB3 at 1 uM by Ambit competition binding assay	B	O=C(c1ccc(-c2ccccn2)s1)N1N=C(c2cccnc2)CC1c1ccccc1O		CHEMBL1778666	=	Inhibition	%	65.0	CHEMBL4901	Homo sapiens	INH	%	65.0
	6274413	CHEMBL1806277	Inhibition of EPHB3 assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	72.0	CHEMBL4901	Homo sapiens	Activity	%	72.0
	6340998	CHEMBL1827584	Activity of EPHB3 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	99.0	CHEMBL4901	Homo sapiens	Activity	%	99.0
	6352204	CHEMBL1825741	Inhibition of EPH-B3 assessed as residual activity at 10 uM by radioactivity assay in presence of 20 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	45.0	CHEMBL4901	Homo sapiens	Activity	%	45.0
	7567353	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7567812	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7568309	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	340.0	CHEMBL4901	Homo sapiens	Kd	nM	340.0
	7568741	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7569326	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7569816	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7570279	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7570706	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7571302	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7571317	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7571793	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7572256	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7572672	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	1900.0	CHEMBL4901	Homo sapiens	Kd	nM	1900.0
	7573298	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	6.9	CHEMBL4901	Homo sapiens	Kd	nM	6.9
	7573774	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7574243	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7574651	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7574819	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7575280	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7575751	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7576216	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7576624	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7576793	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7577252	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	85.0	CHEMBL4901	Homo sapiens	Kd	nM	85.0
	7577730	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7578200	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7578605	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7578801	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7579175	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7579625	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7580099	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7581159	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7581544	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7581989	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7582482	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7582882	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7583505	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	1400.0	CHEMBL4901	Homo sapiens	Kd	nM	1400.0
	7583902	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7584347	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7584376	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7584838	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7585242	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7585835	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7586243	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7586718	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7587172	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7588226	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7588697	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7589148	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7589319	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7589743	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7590210	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7590684	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7591135	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7591292	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7591714	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7592186	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7592659	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	3500.0	CHEMBL4901	Homo sapiens	Kd	nM	3500.0
	7593112	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	210.0	CHEMBL4901	Homo sapiens	Kd	nM	210.0
	7593259	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7593694	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7594166	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7594639	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	1000.0	CHEMBL4901	Homo sapiens	Kd	nM	1000.0
	7595227	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7595671	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7596145	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7596621	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7597199	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7597652	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7598125	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7598153	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7598595	CHEMBL1908652	Binding constant for EPHB3 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Kd	nM	10000.0	CHEMBL4901	Homo sapiens	Kd	nM	10000.0
	7931145	CHEMBL1919061	Inhibition of EPHB3 relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
	7931146	CHEMBL1919061	Inhibition of EPHB3 relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	IC50	nM	350.0	CHEMBL4901	Homo sapiens	IC50	nM	350.0
	7959749	CHEMBL1932849	Inhibition of EPHB3	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL4901	Homo sapiens	IC50	uM	30.0
	7959750	CHEMBL1932849	Inhibition of EPHB3	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	9400.0	CHEMBL4901	Homo sapiens	IC50	uM	9.4
	7969718	CHEMBL1931218	Inhibition of EPHB3 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	7.0	CHEMBL4901	Homo sapiens	Activity	%	7.0
	8039806	CHEMBL1952842	Inhibition of EphB3	B	COc1ccc(N2Cc3cnc(Nc4ccccc4)nc3N([C@@H]3CC[C@@H](O)C3)C2=O)cc1		CHEMBL1952210	=	IC50	nM	1090.0	CHEMBL4901	Homo sapiens	IC50	nM	1090.0
	8061372	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	5.47	CHEMBL4901	Homo sapiens	Inhibition	%	5.47
	8061549	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-0.1	CHEMBL4901	Homo sapiens	Inhibition	%	-0.1
	8061656	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	4.66	CHEMBL4901	Homo sapiens	Inhibition	%	4.66
	8061880	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.3	CHEMBL4901	Homo sapiens	Inhibition	%	2.3
	8062071	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	4.59	CHEMBL4901	Homo sapiens	Inhibition	%	4.59
	8062411	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.54	CHEMBL4901	Homo sapiens	Inhibition	%	3.54
	8062573	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.83	CHEMBL4901	Homo sapiens	Inhibition	%	1.83
	8062895	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-1.68	CHEMBL4901	Homo sapiens	Inhibition	%	-1.68
	8063251	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	12.85	CHEMBL4901	Homo sapiens	Inhibition	%	12.85
	8063418	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	3.56	CHEMBL4901	Homo sapiens	Inhibition	%	3.56
	8063750	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	4.63	CHEMBL4901	Homo sapiens	Inhibition	%	4.63
	8063932	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	-0.71	CHEMBL4901	Homo sapiens	Inhibition	%	-0.71
	8064271	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.62	CHEMBL4901	Homo sapiens	Inhibition	%	4.62
	8064481	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	2.5	CHEMBL4901	Homo sapiens	Inhibition	%	2.5
	8064843	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	2.4	CHEMBL4901	Homo sapiens	Inhibition	%	2.4
	8065009	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	4.88	CHEMBL4901	Homo sapiens	Inhibition	%	4.88
	8065349	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.89	CHEMBL4901	Homo sapiens	Inhibition	%	1.89
	8065524	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	5.94	CHEMBL4901	Homo sapiens	Inhibition	%	5.94
	8065748	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	3.0	CHEMBL4901	Homo sapiens	Inhibition	%	3.0
	8065863	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	4.18	CHEMBL4901	Homo sapiens	Inhibition	%	4.18
	8066073	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-1.81	CHEMBL4901	Homo sapiens	Inhibition	%	-1.81
	8066297	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.73	CHEMBL4901	Homo sapiens	Inhibition	%	2.73
	8066433	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-5.15	CHEMBL4901	Homo sapiens	Inhibition	%	-5.15
	8066599	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	3.22	CHEMBL4901	Homo sapiens	Inhibition	%	3.22
	8066823	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.79	CHEMBL4901	Homo sapiens	Inhibition	%	2.79
	8066947	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	5.42	CHEMBL4901	Homo sapiens	Inhibition	%	5.42
	8067346	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	5.22	CHEMBL4901	Homo sapiens	Inhibition	%	5.22
	8067467	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	3.26	CHEMBL4901	Homo sapiens	Inhibition	%	3.26
	8067901	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-3.8	CHEMBL4901	Homo sapiens	Inhibition	%	-3.8
	8068036	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	3.58	CHEMBL4901	Homo sapiens	Inhibition	%	3.58
	8068424	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	3.66	CHEMBL4901	Homo sapiens	Inhibition	%	3.66
	8068549	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	7.66	CHEMBL4901	Homo sapiens	Inhibition	%	7.66
	8068773	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.46	CHEMBL4901	Homo sapiens	Inhibition	%	2.46
	8068947	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.8	CHEMBL4901	Homo sapiens	Inhibition	%	0.8
	8069072	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	4.48	CHEMBL4901	Homo sapiens	Inhibition	%	4.48
	8069296	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	8.05	CHEMBL4901	Homo sapiens	Inhibition	%	8.05
	8069367	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	-3.61	CHEMBL4901	Homo sapiens	Inhibition	%	-3.61
	8069591	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	2.17	CHEMBL4901	Homo sapiens	Inhibition	%	2.17
	8069752	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.53	CHEMBL4901	Homo sapiens	Inhibition	%	1.53
	8070102	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	3.74	CHEMBL4901	Homo sapiens	Inhibition	%	3.74
	8070274	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	5.38	CHEMBL4901	Homo sapiens	Inhibition	%	5.38
	8070623	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	3.79	CHEMBL4901	Homo sapiens	Inhibition	%	3.79
	8070921	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	0.09	CHEMBL4901	Homo sapiens	Inhibition	%	0.09
	8071078	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	3.65	CHEMBL4901	Homo sapiens	Inhibition	%	3.65
	8071428	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	2.71	CHEMBL4901	Homo sapiens	Inhibition	%	2.71
	8071601	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	4.12	CHEMBL4901	Homo sapiens	Inhibition	%	4.12
	8071950	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.74	CHEMBL4901	Homo sapiens	Inhibition	%	1.74
	8072264	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	2.88	CHEMBL4901	Homo sapiens	Inhibition	%	2.88
	8072421	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.13	CHEMBL4901	Homo sapiens	Inhibition	%	1.13
	8072645	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	3.87	CHEMBL4901	Homo sapiens	Inhibition	%	3.87
	8072770	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.95	CHEMBL4901	Homo sapiens	Inhibition	%	1.95
	8072937	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.64	CHEMBL4901	Homo sapiens	Inhibition	%	4.64
	8073161	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.95	CHEMBL4901	Homo sapiens	Inhibition	%	3.95
	8073286	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	16.79	CHEMBL4901	Homo sapiens	Inhibition	%	16.79
	8073629	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	2.46	CHEMBL4901	Homo sapiens	Inhibition	%	2.46
	8073862	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.33	CHEMBL4901	Homo sapiens	Inhibition	%	0.33
	8074238	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.72	CHEMBL4901	Homo sapiens	Inhibition	%	1.72
	8074368	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	2.32	CHEMBL4901	Homo sapiens	Inhibition	%	2.32
	8074749	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.13	CHEMBL4901	Homo sapiens	Inhibition	%	3.13
	8074876	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	36.64	CHEMBL4901	Homo sapiens	Inhibition	%	36.64
	8075100	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	1.16	CHEMBL4901	Homo sapiens	Inhibition	%	1.16
	8075211	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.26	CHEMBL4901	Homo sapiens	Inhibition	%	-0.26
	8075448	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	2.42	CHEMBL4901	Homo sapiens	Inhibition	%	2.42
	8075813	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	10.61	CHEMBL4901	Homo sapiens	Inhibition	%	10.61
	8075955	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.33	CHEMBL4901	Homo sapiens	Inhibition	%	0.33
	8076179	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.32	CHEMBL4901	Homo sapiens	Inhibition	%	1.32
	8076327	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	4.05	CHEMBL4901	Homo sapiens	Inhibition	%	4.05
	8076685	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.4	CHEMBL4901	Homo sapiens	Inhibition	%	0.4
	8076787	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.51	CHEMBL4901	Homo sapiens	Inhibition	%	2.51
	8077011	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-2.79	CHEMBL4901	Homo sapiens	Inhibition	%	-2.79
	8077034	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-2.06	CHEMBL4901	Homo sapiens	Inhibition	%	-2.06
	8077258	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	1.57	CHEMBL4901	Homo sapiens	Inhibition	%	1.57
	8077386	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	4.29	CHEMBL4901	Homo sapiens	Inhibition	%	4.29
	8077761	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.52	CHEMBL4901	Homo sapiens	Inhibition	%	0.52
	8077904	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.67	CHEMBL4901	Homo sapiens	Inhibition	%	2.67
	8078267	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-8.08	CHEMBL4901	Homo sapiens	Inhibition	%	-8.08
	8078593	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.51	CHEMBL4901	Homo sapiens	Inhibition	%	2.51
	8078843	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-3.07	CHEMBL4901	Homo sapiens	Inhibition	%	-3.07
	8078959	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.01	CHEMBL4901	Homo sapiens	Inhibition	%	4.01
	8079183	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.32	CHEMBL4901	Homo sapiens	Inhibition	%	4.32
	8079341	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-1.05	CHEMBL4901	Homo sapiens	Inhibition	%	-1.05
	8079483	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.11	CHEMBL4901	Homo sapiens	Inhibition	%	2.11
	8079707	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.15	CHEMBL4901	Homo sapiens	Inhibition	%	3.15
	8079846	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-5.11	CHEMBL4901	Homo sapiens	Inhibition	%	-5.11
	8080175	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-3.73	CHEMBL4901	Homo sapiens	Inhibition	%	-3.73
	8080427	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	0.34	CHEMBL4901	Homo sapiens	Inhibition	%	0.34
	8080766	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	4.29	CHEMBL4901	Homo sapiens	Inhibition	%	4.29
	8080930	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.83	CHEMBL4901	Homo sapiens	Inhibition	%	-0.83
	8081289	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.61	CHEMBL4901	Homo sapiens	Inhibition	%	1.61
	8081433	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	7.06	CHEMBL4901	Homo sapiens	Inhibition	%	7.06
	8081760	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	2.73	CHEMBL4901	Homo sapiens	Inhibition	%	2.73
	8082012	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-4.87	CHEMBL4901	Homo sapiens	Inhibition	%	-4.87
	8082349	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.66	CHEMBL4901	Homo sapiens	Inhibition	%	1.66
	8082522	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-8.29	CHEMBL4901	Homo sapiens	Inhibition	%	-8.29
	8082869	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.94	CHEMBL4901	Homo sapiens	Inhibition	%	3.94
	8083025	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	2.33	CHEMBL4901	Homo sapiens	Inhibition	%	2.33
	8083249	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	5.75	CHEMBL4901	Homo sapiens	Inhibition	%	5.75
	8083348	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-5.14	CHEMBL4901	Homo sapiens	Inhibition	%	-5.14
	8083602	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.43	CHEMBL4901	Homo sapiens	Inhibition	%	-1.43
	8083936	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	4.01	CHEMBL4901	Homo sapiens	Inhibition	%	4.01
	8084121	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-2.02	CHEMBL4901	Homo sapiens	Inhibition	%	-2.02
	8084345	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	2.75	CHEMBL4901	Homo sapiens	Inhibition	%	2.75
	8084463	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.11	CHEMBL4901	Homo sapiens	Inhibition	%	1.11
	8084848	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	4.37	CHEMBL4901	Homo sapiens	Inhibition	%	4.37
	8084946	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	4.48	CHEMBL4901	Homo sapiens	Inhibition	%	4.48
	8085170	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-3.94	CHEMBL4901	Homo sapiens	Inhibition	%	-3.94
	8085202	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-4.08	CHEMBL4901	Homo sapiens	Inhibition	%	-4.08
	8085426	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-7.53	CHEMBL4901	Homo sapiens	Inhibition	%	-7.53
	8085534	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.1	CHEMBL4901	Homo sapiens	Inhibition	%	1.1
	8085947	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	-3.76	CHEMBL4901	Homo sapiens	Inhibition	%	-3.76
	8086062	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	4.69	CHEMBL4901	Homo sapiens	Inhibition	%	4.69
	8086286	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.55	CHEMBL4901	Homo sapiens	Inhibition	%	1.55
	8086448	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.14	CHEMBL4901	Homo sapiens	Inhibition	%	1.14
	8086771	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.91	CHEMBL4901	Homo sapiens	Inhibition	%	2.91
	8086982	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-2.12	CHEMBL4901	Homo sapiens	Inhibition	%	-2.12
	8087140	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	6.32	CHEMBL4901	Homo sapiens	Inhibition	%	6.32
	8087364	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.63	CHEMBL4901	Homo sapiens	Inhibition	%	2.63
	8087478	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	6.04	CHEMBL4901	Homo sapiens	Inhibition	%	6.04
	8087840	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.63	CHEMBL4901	Homo sapiens	Inhibition	%	4.63
	8087982	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.36	CHEMBL4901	Homo sapiens	Inhibition	%	3.36
	8088206	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.77	CHEMBL4901	Homo sapiens	Inhibition	%	3.77
	8088354	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.56	CHEMBL4901	Homo sapiens	Inhibition	%	0.56
	8088706	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.27	CHEMBL4901	Homo sapiens	Inhibition	%	3.27
	8088799	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	5.49	CHEMBL4901	Homo sapiens	Inhibition	%	5.49
	8089023	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.17	CHEMBL4901	Homo sapiens	Inhibition	%	2.17
	8089151	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.47	CHEMBL4901	Homo sapiens	Inhibition	%	1.47
	8089523	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	2.65	CHEMBL4901	Homo sapiens	Inhibition	%	2.65
	8089643	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	2.51	CHEMBL4901	Homo sapiens	Inhibition	%	2.51
	8090047	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	3.25	CHEMBL4901	Homo sapiens	Inhibition	%	3.25
	8090212	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.98	CHEMBL4901	Homo sapiens	Inhibition	%	1.98
	8090603	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.93	CHEMBL4901	Homo sapiens	Inhibition	%	2.93
	8090742	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.33	CHEMBL4901	Homo sapiens	Inhibition	%	2.33
	8091171	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	5.28	CHEMBL4901	Homo sapiens	Inhibition	%	5.28
	8091308	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	2.92	CHEMBL4901	Homo sapiens	Inhibition	%	2.92
	8091687	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	4.65	CHEMBL4901	Homo sapiens	Inhibition	%	4.65
	8091803	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	2.82	CHEMBL4901	Homo sapiens	Inhibition	%	2.82
	8092027	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.43	CHEMBL4901	Homo sapiens	Inhibition	%	3.43
	8092164	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-0.53	CHEMBL4901	Homo sapiens	Inhibition	%	-0.53
	8092539	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	0.62	CHEMBL4901	Homo sapiens	Inhibition	%	0.62
	8092687	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	2.36	CHEMBL4901	Homo sapiens	Inhibition	%	2.36
	8093040	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.66	CHEMBL4901	Homo sapiens	Inhibition	%	3.66
	8093352	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	4.77	CHEMBL4901	Homo sapiens	Inhibition	%	4.77
	8093492	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-1.18	CHEMBL4901	Homo sapiens	Inhibition	%	-1.18
	8093855	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	-0.21	CHEMBL4901	Homo sapiens	Inhibition	%	-0.21
	8093975	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	4.07	CHEMBL4901	Homo sapiens	Inhibition	%	4.07
	8094199	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	3.23	CHEMBL4901	Homo sapiens	Inhibition	%	3.23
	8094379	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.39	CHEMBL4901	Homo sapiens	Inhibition	%	0.39
	8094554	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.18	CHEMBL4901	Homo sapiens	Inhibition	%	0.18
	8094778	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	2.78	CHEMBL4901	Homo sapiens	Inhibition	%	2.78
	8094934	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.76	CHEMBL4901	Homo sapiens	Inhibition	%	3.76
	8095074	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	3.87	CHEMBL4901	Homo sapiens	Inhibition	%	3.87
	8095298	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	8.25	CHEMBL4901	Homo sapiens	Inhibition	%	8.25
	8095501	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	5.08	CHEMBL4901	Homo sapiens	Inhibition	%	5.08
	8095642	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	1.76	CHEMBL4901	Homo sapiens	Inhibition	%	1.76
	8095866	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	2.4	CHEMBL4901	Homo sapiens	Inhibition	%	2.4
	8096014	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.93	CHEMBL4901	Homo sapiens	Inhibition	%	2.93
	8096355	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.85	CHEMBL4901	Homo sapiens	Inhibition	%	2.85
	8096494	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-0.5	CHEMBL4901	Homo sapiens	Inhibition	%	-0.5
	8096874	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.6	CHEMBL4901	Homo sapiens	Inhibition	%	4.6
	8097021	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.38	CHEMBL4901	Homo sapiens	Inhibition	%	0.38
	8097245	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.19	CHEMBL4901	Homo sapiens	Inhibition	%	2.19
	8097332	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.43	CHEMBL4901	Homo sapiens	Inhibition	%	0.43
	8097552	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.45	CHEMBL4901	Homo sapiens	Inhibition	%	1.45
	8097702	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	0.34	CHEMBL4901	Homo sapiens	Inhibition	%	0.34
	8097926	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-0.22	CHEMBL4901	Homo sapiens	Inhibition	%	-0.22
	8098059	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-0.56	CHEMBL4901	Homo sapiens	Inhibition	%	-0.56
	8098403	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.5	CHEMBL4901	Homo sapiens	Inhibition	%	0.5
	8098583	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	4.16	CHEMBL4901	Homo sapiens	Inhibition	%	4.16
	8098992	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	2.03	CHEMBL4901	Homo sapiens	Inhibition	%	2.03
	8099136	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.83	CHEMBL4901	Homo sapiens	Inhibition	%	3.83
	8099502	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.62	CHEMBL4901	Homo sapiens	Inhibition	%	3.62
	8099696	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	5.62	CHEMBL4901	Homo sapiens	Inhibition	%	5.62
	8100067	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	2.7	CHEMBL4901	Homo sapiens	Inhibition	%	2.7
	8100213	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	4.39	CHEMBL4901	Homo sapiens	Inhibition	%	4.39
	8100553	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.25	CHEMBL4901	Homo sapiens	Inhibition	%	4.25
	8100693	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.63	CHEMBL4901	Homo sapiens	Inhibition	%	0.63
	8100917	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.88	CHEMBL4901	Homo sapiens	Inhibition	%	1.88
	8101077	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.97	CHEMBL4901	Homo sapiens	Inhibition	%	3.97
	8101443	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-5.87	CHEMBL4901	Homo sapiens	Inhibition	%	-5.87
	8101628	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.01	CHEMBL4901	Homo sapiens	Inhibition	%	0.01
	8101881	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	3.32	CHEMBL4901	Homo sapiens	Inhibition	%	3.32
	8102260	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-3.41	CHEMBL4901	Homo sapiens	Inhibition	%	-3.41
	8102391	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-3.97	CHEMBL4901	Homo sapiens	Inhibition	%	-3.97
	8102735	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	2.27	CHEMBL4901	Homo sapiens	Inhibition	%	2.27
	8102913	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.82	CHEMBL4901	Homo sapiens	Inhibition	%	0.82
	8103137	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	3.5	CHEMBL4901	Homo sapiens	Inhibition	%	3.5
	8103333	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	0.72	CHEMBL4901	Homo sapiens	Inhibition	%	0.72
	8103471	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	4.34	CHEMBL4901	Homo sapiens	Inhibition	%	4.34
	8103695	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	2.13	CHEMBL4901	Homo sapiens	Inhibition	%	2.13
	8103845	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.29	CHEMBL4901	Homo sapiens	Inhibition	%	3.29
	8104030	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	4.39	CHEMBL4901	Homo sapiens	Inhibition	%	4.39
	8104402	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	4.17	CHEMBL4901	Homo sapiens	Inhibition	%	4.17
	8104548	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-2.23	CHEMBL4901	Homo sapiens	Inhibition	%	-2.23
	8104772	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-3.53	CHEMBL4901	Homo sapiens	Inhibition	%	-3.53
	8104886	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	5.17	CHEMBL4901	Homo sapiens	Inhibition	%	5.17
	8105250	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.0	CHEMBL4901	Homo sapiens	Inhibition	%	1.0
	8105416	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.63	CHEMBL4901	Homo sapiens	Inhibition	%	3.63
	8105778	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-2.19	CHEMBL4901	Homo sapiens	Inhibition	%	-2.19
	8106058	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	4.08	CHEMBL4901	Homo sapiens	Inhibition	%	4.08
	8106223	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	-5.7	CHEMBL4901	Homo sapiens	Inhibition	%	-5.7
	8106447	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.41	CHEMBL4901	Homo sapiens	Inhibition	%	0.41
	8106603	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	4.33	CHEMBL4901	Homo sapiens	Inhibition	%	4.33
	8106732	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	3.77	CHEMBL4901	Homo sapiens	Inhibition	%	3.77
	8106956	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.54	CHEMBL4901	Homo sapiens	Inhibition	%	0.54
	8107077	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.02	CHEMBL4901	Homo sapiens	Inhibition	%	0.02
	8107473	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.68	CHEMBL4901	Homo sapiens	Inhibition	%	1.68
	8107674	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.06	CHEMBL4901	Homo sapiens	Inhibition	%	1.06
	8108033	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	2.83	CHEMBL4901	Homo sapiens	Inhibition	%	2.83
	8108191	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	4.48	CHEMBL4901	Homo sapiens	Inhibition	%	4.48
	8108366	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	4.58	CHEMBL4901	Homo sapiens	Inhibition	%	4.58
	8108590	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	5.18	CHEMBL4901	Homo sapiens	Inhibition	%	5.18
	8108737	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	2.8	CHEMBL4901	Homo sapiens	Inhibition	%	2.8
	8109103	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.47	CHEMBL4901	Homo sapiens	Inhibition	%	-0.47
	8109217	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	5.31	CHEMBL4901	Homo sapiens	Inhibition	%	5.31
	8109441	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.14	CHEMBL4901	Homo sapiens	Inhibition	%	3.14
	8109571	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.14	CHEMBL4901	Homo sapiens	Inhibition	%	2.14
	8109742	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-1.42	CHEMBL4901	Homo sapiens	Inhibition	%	-1.42
	8109966	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-0.38	CHEMBL4901	Homo sapiens	Inhibition	%	-0.38
	8110098	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.34	CHEMBL4901	Homo sapiens	Inhibition	%	3.34
	8110377	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.84	CHEMBL4901	Homo sapiens	Inhibition	%	0.84
	8110767	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-0.85	CHEMBL4901	Homo sapiens	Inhibition	%	-0.85
	8110925	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-7.45	CHEMBL4901	Homo sapiens	Inhibition	%	-7.45
	8111272	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	6.29	CHEMBL4901	Homo sapiens	Inhibition	%	6.29
	8111399	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.9	CHEMBL4901	Homo sapiens	Inhibition	%	0.9
	8111623	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.27	CHEMBL4901	Homo sapiens	Inhibition	%	-0.27
	8111789	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	3.79	CHEMBL4901	Homo sapiens	Inhibition	%	3.79
	8111994	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.56	CHEMBL4901	Homo sapiens	Inhibition	%	1.56
	8112355	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.98	CHEMBL4901	Homo sapiens	Inhibition	%	1.98
	8112523	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.52	CHEMBL4901	Homo sapiens	Inhibition	%	3.52
	8112919	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	3.15	CHEMBL4901	Homo sapiens	Inhibition	%	3.15
	8113071	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	6.12	CHEMBL4901	Homo sapiens	Inhibition	%	6.12
	8113431	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	3.29	CHEMBL4901	Homo sapiens	Inhibition	%	3.29
	8113779	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	5.07	CHEMBL4901	Homo sapiens	Inhibition	%	5.07
	8113895	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-5.75	CHEMBL4901	Homo sapiens	Inhibition	%	-5.75
	8114295	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.02	CHEMBL4901	Homo sapiens	Inhibition	%	3.02
	8114427	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.15	CHEMBL4901	Homo sapiens	Inhibition	%	3.15
	8114703	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	5.37	CHEMBL4901	Homo sapiens	Inhibition	%	5.37
	8115093	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	26.45	CHEMBL4901	Homo sapiens	Inhibition	%	26.45
	8115258	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	1.18	CHEMBL4901	Homo sapiens	Inhibition	%	1.18
	8115602	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	3.66	CHEMBL4901	Homo sapiens	Inhibition	%	3.66
	8115959	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.62	CHEMBL4901	Homo sapiens	Inhibition	%	0.62
	8116118	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.32	CHEMBL4901	Homo sapiens	Inhibition	%	-0.32
	8116321	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.29	CHEMBL4901	Homo sapiens	Inhibition	%	2.29
	8116545	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.01	CHEMBL4901	Homo sapiens	Inhibition	%	3.01
	8116679	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.96	CHEMBL4901	Homo sapiens	Inhibition	%	0.96
	8116851	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	9.18	CHEMBL4901	Homo sapiens	Inhibition	%	9.18
	8117075	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	21.96	CHEMBL4901	Homo sapiens	Inhibition	%	21.96
	8117246	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	2.98	CHEMBL4901	Homo sapiens	Inhibition	%	2.98
	8117404	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	-3.04	CHEMBL4901	Homo sapiens	Inhibition	%	-3.04
	8117628	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	4.0	CHEMBL4901	Homo sapiens	Inhibition	%	4.0
	8117758	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-0.46	CHEMBL4901	Homo sapiens	Inhibition	%	-0.46
	8118120	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-0.46	CHEMBL4901	Homo sapiens	Inhibition	%	-0.46
	8118236	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-2.65	CHEMBL4901	Homo sapiens	Inhibition	%	-2.65
	8118460	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.93	CHEMBL4901	Homo sapiens	Inhibition	%	1.93
	8118632	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.57	CHEMBL4901	Homo sapiens	Inhibition	%	3.57
	8118768	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	5.55	CHEMBL4901	Homo sapiens	Inhibition	%	5.55
	8118992	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.99	CHEMBL4901	Homo sapiens	Inhibition	%	4.99
	8119039	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.76	CHEMBL4901	Homo sapiens	Inhibition	%	1.76
	8119263	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	4.52	CHEMBL4901	Homo sapiens	Inhibition	%	4.52
	8119422	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	63.53	CHEMBL4901	Homo sapiens	Inhibition	%	63.53
	8119589	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-4.13	CHEMBL4901	Homo sapiens	Inhibition	%	-4.13
	8119813	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-1.83	CHEMBL4901	Homo sapiens	Inhibition	%	-1.83
	8119932	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	6.15	CHEMBL4901	Homo sapiens	Inhibition	%	6.15
	8120295	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.21	CHEMBL4901	Homo sapiens	Inhibition	%	-0.21
	8120455	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.79	CHEMBL4901	Homo sapiens	Inhibition	%	0.79
	8120679	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.25	CHEMBL4901	Homo sapiens	Inhibition	%	-0.25
	8120880	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	4.06	CHEMBL4901	Homo sapiens	Inhibition	%	4.06
	8121008	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.49	CHEMBL4901	Homo sapiens	Inhibition	%	0.49
	8121404	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	4.37	CHEMBL4901	Homo sapiens	Inhibition	%	4.37
	8121571	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	2.41	CHEMBL4901	Homo sapiens	Inhibition	%	2.41
	8121958	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.52	CHEMBL4901	Homo sapiens	Inhibition	%	4.52
	8122079	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	2.9	CHEMBL4901	Homo sapiens	Inhibition	%	2.9
	8122303	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	1.64	CHEMBL4901	Homo sapiens	Inhibition	%	1.64
	8122441	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.58	CHEMBL4901	Homo sapiens	Inhibition	%	1.58
	8122785	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	4.65	CHEMBL4901	Homo sapiens	Inhibition	%	4.65
	8122952	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.21	CHEMBL4901	Homo sapiens	Inhibition	%	4.21
	8123318	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	1.32	CHEMBL4901	Homo sapiens	Inhibition	%	1.32
	8123596	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.2	CHEMBL4901	Homo sapiens	Inhibition	%	0.2
	8123746	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	3.59	CHEMBL4901	Homo sapiens	Inhibition	%	3.59
	8124137	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-8.69	CHEMBL4901	Homo sapiens	Inhibition	%	-8.69
	8124256	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	9.44	CHEMBL4901	Homo sapiens	Inhibition	%	9.44
	8124480	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	1.65	CHEMBL4901	Homo sapiens	Inhibition	%	1.65
	8124619	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.22	CHEMBL4901	Homo sapiens	Inhibition	%	2.22
	8125008	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.72	CHEMBL4901	Homo sapiens	Inhibition	%	2.72
	8125209	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.55	CHEMBL4901	Homo sapiens	Inhibition	%	4.55
	8125339	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	1.76	CHEMBL4901	Homo sapiens	Inhibition	%	1.76
	8125563	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.63	CHEMBL4901	Homo sapiens	Inhibition	%	0.63
	8125731	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	3.49	CHEMBL4901	Homo sapiens	Inhibition	%	3.49
	8125895	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	2.85	CHEMBL4901	Homo sapiens	Inhibition	%	2.85
	8126119	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.69	CHEMBL4901	Homo sapiens	Inhibition	%	0.69
	8126283	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	6.83	CHEMBL4901	Homo sapiens	Inhibition	%	6.83
	8126622	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	51.11	CHEMBL4901	Homo sapiens	Inhibition	%	51.11
	8126758	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	2.97	CHEMBL4901	Homo sapiens	Inhibition	%	2.97
	8127104	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.75	CHEMBL4901	Homo sapiens	Inhibition	%	4.75
	8127271	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.97	CHEMBL4901	Homo sapiens	Inhibition	%	4.97
	8127495	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	3.05	CHEMBL4901	Homo sapiens	Inhibition	%	3.05
	8127637	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	0.77	CHEMBL4901	Homo sapiens	Inhibition	%	0.77
	8127925	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	4.24	CHEMBL4901	Homo sapiens	Inhibition	%	4.24
	8128077	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	-2.55	CHEMBL4901	Homo sapiens	Inhibition	%	-2.55
	8128301	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	5.26	CHEMBL4901	Homo sapiens	Inhibition	%	5.26
	8128468	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-4.51	CHEMBL4901	Homo sapiens	Inhibition	%	-4.51
	8128811	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	-3.88	CHEMBL4901	Homo sapiens	Inhibition	%	-3.88
	8128948	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.61	CHEMBL4901	Homo sapiens	Inhibition	%	1.61
	8129343	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.49	CHEMBL4901	Homo sapiens	Inhibition	%	-0.49
	8129532	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.56	CHEMBL4901	Homo sapiens	Inhibition	%	4.56
	8129895	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	2.01	CHEMBL4901	Homo sapiens	Inhibition	%	2.01
	8130056	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	4.36	CHEMBL4901	Homo sapiens	Inhibition	%	4.36
	8130452	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.64	CHEMBL4901	Homo sapiens	Inhibition	%	1.64
	8130612	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	-0.97	CHEMBL4901	Homo sapiens	Inhibition	%	-0.97
	8130952	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.01	CHEMBL4901	Homo sapiens	Inhibition	%	4.01
	8131091	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	4.36	CHEMBL4901	Homo sapiens	Inhibition	%	4.36
	8131315	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.0	CHEMBL4901	Homo sapiens	Inhibition	%	4.0
	8131435	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.76	CHEMBL4901	Homo sapiens	Inhibition	%	2.76
	8131826	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	6.76	CHEMBL4901	Homo sapiens	Inhibition	%	6.76
	8131967	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	19.58	CHEMBL4901	Homo sapiens	Inhibition	%	19.58
	8132253	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.21	CHEMBL4901	Homo sapiens	Inhibition	%	1.21
	8132624	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	5.69	CHEMBL4901	Homo sapiens	Inhibition	%	5.69
	8132792	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-1.27	CHEMBL4901	Homo sapiens	Inhibition	%	-1.27
	8133137	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.09	CHEMBL4901	Homo sapiens	Inhibition	%	2.09
	8133275	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.06	CHEMBL4901	Homo sapiens	Inhibition	%	3.06
	8133499	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.04	CHEMBL4901	Homo sapiens	Inhibition	%	2.04
	8133671	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	5.63	CHEMBL4901	Homo sapiens	Inhibition	%	5.63
	8133851	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.73	CHEMBL4901	Homo sapiens	Inhibition	%	2.73
	8134075	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	3.2	CHEMBL4901	Homo sapiens	Inhibition	%	3.2
	8134223	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.39	CHEMBL4901	Homo sapiens	Inhibition	%	-1.39
	8134383	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.96	CHEMBL4901	Homo sapiens	Inhibition	%	3.96
	8134607	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	3.21	CHEMBL4901	Homo sapiens	Inhibition	%	3.21
	8134791	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-5.53	CHEMBL4901	Homo sapiens	Inhibition	%	-5.53
	8134951	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	0.55	CHEMBL4901	Homo sapiens	Inhibition	%	0.55
	8135175	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.22	CHEMBL4901	Homo sapiens	Inhibition	%	2.22
	8135290	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.79	CHEMBL4901	Homo sapiens	Inhibition	%	4.79
	8135655	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	7.2	CHEMBL4901	Homo sapiens	Inhibition	%	7.2
	8135776	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-0.03	CHEMBL4901	Homo sapiens	Inhibition	%	-0.03
	8136000	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-1.49	CHEMBL4901	Homo sapiens	Inhibition	%	-1.49
	8136168	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.82	CHEMBL4901	Homo sapiens	Inhibition	%	1.82
	8136312	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	68.25	CHEMBL4901	Homo sapiens	Inhibition	%	68.25
	8136536	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	5.97	CHEMBL4901	Homo sapiens	Inhibition	%	5.97
	8136602	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-1.17	CHEMBL4901	Homo sapiens	Inhibition	%	-1.17
	8136826	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-3.39	CHEMBL4901	Homo sapiens	Inhibition	%	-3.39
	8136961	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	3.28	CHEMBL4901	Homo sapiens	Inhibition	%	3.28
	8137124	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.05	CHEMBL4901	Homo sapiens	Inhibition	%	1.05
	8137348	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	-1.29	CHEMBL4901	Homo sapiens	Inhibition	%	-1.29
	8137468	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.0	CHEMBL4901	Homo sapiens	Inhibition	%	2.0
	8137840	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	5.11	CHEMBL4901	Homo sapiens	Inhibition	%	5.11
	8138006	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	3.63	CHEMBL4901	Homo sapiens	Inhibition	%	3.63
	8138409	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.8	CHEMBL4901	Homo sapiens	Inhibition	%	2.8
	8138557	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.05	CHEMBL4901	Homo sapiens	Inhibition	%	0.05
	8138939	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	3.35	CHEMBL4901	Homo sapiens	Inhibition	%	3.35
	8139124	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-3.88	CHEMBL4901	Homo sapiens	Inhibition	%	-3.88
	8139507	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	4.35	CHEMBL4901	Homo sapiens	Inhibition	%	4.35
	8139621	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.9	CHEMBL4901	Homo sapiens	Inhibition	%	2.9
	8139986	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.69	CHEMBL4901	Homo sapiens	Inhibition	%	3.69
	8140333	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.77	CHEMBL4901	Homo sapiens	Inhibition	%	2.77
	8140492	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.68	CHEMBL4901	Homo sapiens	Inhibition	%	3.68
	8140859	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.71	CHEMBL4901	Homo sapiens	Inhibition	%	3.71
	8141161	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.82	CHEMBL4901	Homo sapiens	Inhibition	%	2.82
	8141291	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	2.88	CHEMBL4901	Homo sapiens	Inhibition	%	2.88
	8141675	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.75	CHEMBL4901	Homo sapiens	Inhibition	%	1.75
	8141794	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-1.0	CHEMBL4901	Homo sapiens	Inhibition	%	-1.0
	8142018	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	2.29	CHEMBL4901	Homo sapiens	Inhibition	%	2.29
	8142179	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	1.77	CHEMBL4901	Homo sapiens	Inhibition	%	1.77
	8142347	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.77	CHEMBL4901	Homo sapiens	Inhibition	%	0.77
	8142571	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-3.13	CHEMBL4901	Homo sapiens	Inhibition	%	-3.13
	8142747	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	3.98	CHEMBL4901	Homo sapiens	Inhibition	%	3.98
	8142896	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-7.05	CHEMBL4901	Homo sapiens	Inhibition	%	-7.05
	8143120	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-4.82	CHEMBL4901	Homo sapiens	Inhibition	%	-4.82
	8143275	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.43	CHEMBL4901	Homo sapiens	Inhibition	%	3.43
	8143462	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	0.93	CHEMBL4901	Homo sapiens	Inhibition	%	0.93
	8143845	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	3.61	CHEMBL4901	Homo sapiens	Inhibition	%	3.61
	8143959	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.77	CHEMBL4901	Homo sapiens	Inhibition	%	3.77
	8144183	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-1.4	CHEMBL4901	Homo sapiens	Inhibition	%	-1.4
	8144322	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	7.49	CHEMBL4901	Homo sapiens	Inhibition	%	7.49
	8144676	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.78	CHEMBL4901	Homo sapiens	Inhibition	%	1.78
	8144829	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.26	CHEMBL4901	Homo sapiens	Inhibition	%	0.26
	8145190	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.95	CHEMBL4901	Homo sapiens	Inhibition	%	4.95
	8145503	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.49	CHEMBL4901	Homo sapiens	Inhibition	%	0.49
	8145627	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	3.53	CHEMBL4901	Homo sapiens	Inhibition	%	3.53
	8145851	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	2.4	CHEMBL4901	Homo sapiens	Inhibition	%	2.4
	8146012	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.02	CHEMBL4901	Homo sapiens	Inhibition	%	2.02
	8146356	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	3.25	CHEMBL4901	Homo sapiens	Inhibition	%	3.25
	8146516	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	6.41	CHEMBL4901	Homo sapiens	Inhibition	%	6.41
	8146907	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.08	CHEMBL4901	Homo sapiens	Inhibition	%	-1.08
	8147076	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.43	CHEMBL4901	Homo sapiens	Inhibition	%	1.43
	8147442	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	5.37	CHEMBL4901	Homo sapiens	Inhibition	%	5.37
	8147595	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.54	CHEMBL4901	Homo sapiens	Inhibition	%	3.54
	8147782	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	5.23	CHEMBL4901	Homo sapiens	Inhibition	%	5.23
	8148006	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	2.1	CHEMBL4901	Homo sapiens	Inhibition	%	2.1
	8148164	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	9.16	CHEMBL4901	Homo sapiens	Inhibition	%	9.16
	8148502	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.23	CHEMBL4901	Homo sapiens	Inhibition	%	-0.23
	8148641	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.21	CHEMBL4901	Homo sapiens	Inhibition	%	3.21
	8148865	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.92	CHEMBL4901	Homo sapiens	Inhibition	%	3.92
	8149003	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.03	CHEMBL4901	Homo sapiens	Inhibition	%	4.03
	8149162	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.7	CHEMBL4901	Homo sapiens	Inhibition	%	3.7
	8149386	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-1.45	CHEMBL4901	Homo sapiens	Inhibition	%	-1.45
	8149520	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.03	CHEMBL4901	Homo sapiens	Inhibition	%	4.03
	8149842	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	5.12	CHEMBL4901	Homo sapiens	Inhibition	%	5.12
	8150191	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	2.25	CHEMBL4901	Homo sapiens	Inhibition	%	2.25
	8150351	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	4.62	CHEMBL4901	Homo sapiens	Inhibition	%	4.62
	8150695	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	11.32	CHEMBL4901	Homo sapiens	Inhibition	%	11.32
	8150860	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	0.25	CHEMBL4901	Homo sapiens	Inhibition	%	0.25
	8151247	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-8.95	CHEMBL4901	Homo sapiens	Inhibition	%	-8.95
	8151424	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	4.59	CHEMBL4901	Homo sapiens	Inhibition	%	4.59
	8151786	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.32	CHEMBL4901	Homo sapiens	Inhibition	%	2.32
	8151940	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	3.95	CHEMBL4901	Homo sapiens	Inhibition	%	3.95
	8152164	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	4.5	CHEMBL4901	Homo sapiens	Inhibition	%	4.5
	8152352	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	3.26	CHEMBL4901	Homo sapiens	Inhibition	%	3.26
	8152510	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.14	CHEMBL4901	Homo sapiens	Inhibition	%	2.14
	8152848	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	2.23	CHEMBL4901	Homo sapiens	Inhibition	%	2.23
	8153211	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.73	CHEMBL4901	Homo sapiens	Inhibition	%	3.73
	8153348	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.75	CHEMBL4901	Homo sapiens	Inhibition	%	3.75
	8153729	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.8	CHEMBL4901	Homo sapiens	Inhibition	%	-0.8
	8153862	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.02	CHEMBL4901	Homo sapiens	Inhibition	%	3.02
	8154086	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.19	CHEMBL4901	Homo sapiens	Inhibition	%	3.19
	8154183	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	6.12	CHEMBL4901	Homo sapiens	Inhibition	%	6.12
	8154533	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	24.22	CHEMBL4901	Homo sapiens	Inhibition	%	24.22
	8154692	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.65	CHEMBL4901	Homo sapiens	Inhibition	%	0.65
	8154916	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.29	CHEMBL4901	Homo sapiens	Inhibition	%	1.29
	8155036	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	3.12	CHEMBL4901	Homo sapiens	Inhibition	%	3.12
	8155212	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.02	CHEMBL4901	Homo sapiens	Inhibition	%	1.02
	8155436	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.56	CHEMBL4901	Homo sapiens	Inhibition	%	-0.56
	8155597	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-5.96	CHEMBL4901	Homo sapiens	Inhibition	%	-5.96
	8155775	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.18	CHEMBL4901	Homo sapiens	Inhibition	%	2.18
	8155999	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.88	CHEMBL4901	Homo sapiens	Inhibition	%	3.88
	8156137	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.96	CHEMBL4901	Homo sapiens	Inhibition	%	3.96
	8156349	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.02	CHEMBL4901	Homo sapiens	Inhibition	%	4.02
	8156573	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	5.13	CHEMBL4901	Homo sapiens	Inhibition	%	5.13
	8156723	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	5.98	CHEMBL4901	Homo sapiens	Inhibition	%	5.98
	8156866	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.17	CHEMBL4901	Homo sapiens	Inhibition	%	4.17
	8157090	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.33	CHEMBL4901	Homo sapiens	Inhibition	%	3.33
	8157210	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	5.28	CHEMBL4901	Homo sapiens	Inhibition	%	5.28
	8157575	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	6.46	CHEMBL4901	Homo sapiens	Inhibition	%	6.46
	8157705	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	8.33	CHEMBL4901	Homo sapiens	Inhibition	%	8.33
	8157929	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	5.54	CHEMBL4901	Homo sapiens	Inhibition	%	5.54
	8158090	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-4.82	CHEMBL4901	Homo sapiens	Inhibition	%	-4.82
	8158340	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	10.87	CHEMBL4901	Homo sapiens	Inhibition	%	10.87
	8158722	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-1.41	CHEMBL4901	Homo sapiens	Inhibition	%	-1.41
	8158891	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	8.17	CHEMBL4901	Homo sapiens	Inhibition	%	8.17
	8159250	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	5.55	CHEMBL4901	Homo sapiens	Inhibition	%	5.55
	8159370	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.94	CHEMBL4901	Homo sapiens	Inhibition	%	2.94
	8159594	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.23	CHEMBL4901	Homo sapiens	Inhibition	%	1.23
	8159725	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	1.98	CHEMBL4901	Homo sapiens	Inhibition	%	1.98
	8160090	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-0.67	CHEMBL4901	Homo sapiens	Inhibition	%	-0.67
	8160227	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.21	CHEMBL4901	Homo sapiens	Inhibition	%	4.21
	8160601	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.08	CHEMBL4901	Homo sapiens	Inhibition	%	1.08
	8160895	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.62	CHEMBL4901	Homo sapiens	Inhibition	%	1.62
	8161045	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	3.86	CHEMBL4901	Homo sapiens	Inhibition	%	3.86
	8161412	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	3.36	CHEMBL4901	Homo sapiens	Inhibition	%	3.36
	8161537	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.84	CHEMBL4901	Homo sapiens	Inhibition	%	2.84
	8161761	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	4.32	CHEMBL4901	Homo sapiens	Inhibition	%	4.32
	8161899	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	3.53	CHEMBL4901	Homo sapiens	Inhibition	%	3.53
	8162253	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.76	CHEMBL4901	Homo sapiens	Inhibition	%	3.76
	8162413	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-3.09	CHEMBL4901	Homo sapiens	Inhibition	%	-3.09
	8162666	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	6.62	CHEMBL4901	Homo sapiens	Inhibition	%	6.62
	8163038	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	5.96	CHEMBL4901	Homo sapiens	Inhibition	%	5.96
	8163207	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.98	CHEMBL4901	Homo sapiens	Inhibition	%	2.98
	8163565	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	5.83	CHEMBL4901	Homo sapiens	Inhibition	%	5.83
	8163912	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.23	CHEMBL4901	Homo sapiens	Inhibition	%	1.23
	8164046	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	6.2	CHEMBL4901	Homo sapiens	Inhibition	%	6.2
	8164410	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	3.09	CHEMBL4901	Homo sapiens	Inhibition	%	3.09
	8164565	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.07	CHEMBL4901	Homo sapiens	Inhibition	%	4.07
	8164933	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	32.07	CHEMBL4901	Homo sapiens	Inhibition	%	32.07
	8165227	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	4.77	CHEMBL4901	Homo sapiens	Inhibition	%	4.77
	8165368	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	4.14	CHEMBL4901	Homo sapiens	Inhibition	%	4.14
	8165592	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.21	CHEMBL4901	Homo sapiens	Inhibition	%	3.21
	8165735	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	6.8	CHEMBL4901	Homo sapiens	Inhibition	%	6.8
	8166085	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.16	CHEMBL4901	Homo sapiens	Inhibition	%	1.16
	8166223	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.94	CHEMBL4901	Homo sapiens	Inhibition	%	3.94
	8166577	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	9.06	CHEMBL4901	Homo sapiens	Inhibition	%	9.06
	8166902	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	0.24	CHEMBL4901	Homo sapiens	Inhibition	%	0.24
	8166990	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.88	CHEMBL4901	Homo sapiens	Inhibition	%	4.88
	8167214	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	6.88	CHEMBL4901	Homo sapiens	Inhibition	%	6.88
	8167355	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	2.98	CHEMBL4901	Homo sapiens	Inhibition	%	2.98
	8167519	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	5.39	CHEMBL4901	Homo sapiens	Inhibition	%	5.39
	8167743	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.56	CHEMBL4901	Homo sapiens	Inhibition	%	3.56
	8167876	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	6.48	CHEMBL4901	Homo sapiens	Inhibition	%	6.48
	8168224	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.4	CHEMBL4901	Homo sapiens	Inhibition	%	3.4
	8168365	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	-1.82	CHEMBL4901	Homo sapiens	Inhibition	%	-1.82
	8168589	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.52	CHEMBL4901	Homo sapiens	Inhibition	%	4.52
	8168725	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.51	CHEMBL4901	Homo sapiens	Inhibition	%	1.51
	8168889	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	4.19	CHEMBL4901	Homo sapiens	Inhibition	%	4.19
	8169113	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	3.9	CHEMBL4901	Homo sapiens	Inhibition	%	3.9
	8169255	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.92	CHEMBL4901	Homo sapiens	Inhibition	%	4.92
	8169559	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	-0.74	CHEMBL4901	Homo sapiens	Inhibition	%	-0.74
	8169917	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.6	CHEMBL4901	Homo sapiens	Inhibition	%	2.6
	8170062	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	6.66	CHEMBL4901	Homo sapiens	Inhibition	%	6.66
	8170411	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	5.12	CHEMBL4901	Homo sapiens	Inhibition	%	5.12
	8170551	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	2.26	CHEMBL4901	Homo sapiens	Inhibition	%	2.26
	8170775	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-0.37	CHEMBL4901	Homo sapiens	Inhibition	%	-0.37
	8170910	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	19.27	CHEMBL4901	Homo sapiens	Inhibition	%	19.27
	8171107	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-6.41	CHEMBL4901	Homo sapiens	Inhibition	%	-6.41
	8171331	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.52	CHEMBL4901	Homo sapiens	Inhibition	%	2.52
	8171548	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	5.06	CHEMBL4901	Homo sapiens	Inhibition	%	5.06
	8171689	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%		CHEMBL4901	Homo sapiens	Inhibition	%	
	8172066	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.95	CHEMBL4901	Homo sapiens	Inhibition	%	0.95
	8172198	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.6	CHEMBL4901	Homo sapiens	Inhibition	%	4.6
	8172422	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	6.46	CHEMBL4901	Homo sapiens	Inhibition	%	6.46
	8172550	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.2	CHEMBL4901	Homo sapiens	Inhibition	%	1.2
	8172916	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.65	CHEMBL4901	Homo sapiens	Inhibition	%	4.65
	8173052	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-3.25	CHEMBL4901	Homo sapiens	Inhibition	%	-3.25
	8173441	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	4.72	CHEMBL4901	Homo sapiens	Inhibition	%	4.72
	8173582	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.97	CHEMBL4901	Homo sapiens	Inhibition	%	4.97
	8173806	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	4.6	CHEMBL4901	Homo sapiens	Inhibition	%	4.6
	8173893	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	3.04	CHEMBL4901	Homo sapiens	Inhibition	%	3.04
	8174249	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	6.09	CHEMBL4901	Homo sapiens	Inhibition	%	6.09
	8174397	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	27.92	CHEMBL4901	Homo sapiens	Inhibition	%	27.92
	8174621	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.55	CHEMBL4901	Homo sapiens	Inhibition	%	3.55
	8174743	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.12	CHEMBL4901	Homo sapiens	Inhibition	%	2.12
	8175110	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-1.35	CHEMBL4901	Homo sapiens	Inhibition	%	-1.35
	8175246	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	6.52	CHEMBL4901	Homo sapiens	Inhibition	%	6.52
	8175502	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	4.57	CHEMBL4901	Homo sapiens	Inhibition	%	4.57
	8175726	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.77	CHEMBL4901	Homo sapiens	Inhibition	%	2.77
	8175889	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	5.14	CHEMBL4901	Homo sapiens	Inhibition	%	5.14
	8176042	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	-7.19	CHEMBL4901	Homo sapiens	Inhibition	%	-7.19
	8176266	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	7.61	CHEMBL4901	Homo sapiens	Inhibition	%	7.61
	8176415	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-0.77	CHEMBL4901	Homo sapiens	Inhibition	%	-0.77
	8176771	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	5.55	CHEMBL4901	Homo sapiens	Inhibition	%	5.55
	8176901	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.4	CHEMBL4901	Homo sapiens	Inhibition	%	1.4
	8177267	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-0.26	CHEMBL4901	Homo sapiens	Inhibition	%	-0.26
	8177405	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-3.05	CHEMBL4901	Homo sapiens	Inhibition	%	-3.05
	8177629	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	0.84	CHEMBL4901	Homo sapiens	Inhibition	%	0.84
	8177793	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	3.82	CHEMBL4901	Homo sapiens	Inhibition	%	3.82
	8178157	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.28	CHEMBL4901	Homo sapiens	Inhibition	%	2.28
	8178245	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	0.13	CHEMBL4901	Homo sapiens	Inhibition	%	0.13
	8178469	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	4.55	CHEMBL4901	Homo sapiens	Inhibition	%	4.55
	8178596	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	11.85	CHEMBL4901	Homo sapiens	Inhibition	%	11.85
	8178969	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.98	CHEMBL4901	Homo sapiens	Inhibition	%	2.98
	8179092	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.91	CHEMBL4901	Homo sapiens	Inhibition	%	3.91
	8179460	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	3.93	CHEMBL4901	Homo sapiens	Inhibition	%	3.93
	8179597	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	2.55	CHEMBL4901	Homo sapiens	Inhibition	%	2.55
	8179821	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	4.42	CHEMBL4901	Homo sapiens	Inhibition	%	4.42
	8180078	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	6.23	CHEMBL4901	Homo sapiens	Inhibition	%	6.23
	8180232	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	4.43	CHEMBL4901	Homo sapiens	Inhibition	%	4.43
	8180612	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	3.86	CHEMBL4901	Homo sapiens	Inhibition	%	3.86
	8180760	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	4.11	CHEMBL4901	Homo sapiens	Inhibition	%	4.11
	8181117	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	96.88	CHEMBL4901	Homo sapiens	Inhibition	%	96.88
	8181248	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.01	CHEMBL4901	Homo sapiens	Inhibition	%	-0.01
	8181472	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-3.87	CHEMBL4901	Homo sapiens	Inhibition	%	-3.87
	8181612	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	5.69	CHEMBL4901	Homo sapiens	Inhibition	%	5.69
	8181975	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	-4.62	CHEMBL4901	Homo sapiens	Inhibition	%	-4.62
	8182138	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	5.51	CHEMBL4901	Homo sapiens	Inhibition	%	5.51
	8182502	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.44	CHEMBL4901	Homo sapiens	Inhibition	%	4.44
	8182818	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	5.69	CHEMBL4901	Homo sapiens	Inhibition	%	5.69
	8182940	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	4.19	CHEMBL4901	Homo sapiens	Inhibition	%	4.19
	8183313	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	3.22	CHEMBL4901	Homo sapiens	Inhibition	%	3.22
	8183442	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	5.16	CHEMBL4901	Homo sapiens	Inhibition	%	5.16
	8183666	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-5.93	CHEMBL4901	Homo sapiens	Inhibition	%	-5.93
	8183808	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	2.6	CHEMBL4901	Homo sapiens	Inhibition	%	2.6
	8184168	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	2.17	CHEMBL4901	Homo sapiens	Inhibition	%	2.17
	8184434	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.08	CHEMBL4901	Homo sapiens	Inhibition	%	4.08
	8184581	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	0.75	CHEMBL4901	Homo sapiens	Inhibition	%	0.75
	8184805	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-2.49	CHEMBL4901	Homo sapiens	Inhibition	%	-2.49
	8184962	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%		CHEMBL4901	Homo sapiens	Inhibition	%	
	8185111	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.83	CHEMBL4901	Homo sapiens	Inhibition	%	1.83
	8185335	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	2.82	CHEMBL4901	Homo sapiens	Inhibition	%	2.82
	8185466	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	97.27	CHEMBL4901	Homo sapiens	Inhibition	%	97.27
	8185821	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-3.57	CHEMBL4901	Homo sapiens	Inhibition	%	-3.57
	8185960	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.9	CHEMBL4901	Homo sapiens	Inhibition	%	2.9
	8186184	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.89	CHEMBL4901	Homo sapiens	Inhibition	%	2.89
	8186325	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.77	CHEMBL4901	Homo sapiens	Inhibition	%	4.77
	8186489	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	5.14	CHEMBL4901	Homo sapiens	Inhibition	%	5.14
	8186713	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.73	CHEMBL4901	Homo sapiens	Inhibition	%	3.73
	8186852	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.93	CHEMBL4901	Homo sapiens	Inhibition	%	1.93
	8187174	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	5.06	CHEMBL4901	Homo sapiens	Inhibition	%	5.06
	8187298	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.79	CHEMBL4901	Homo sapiens	Inhibition	%	3.79
	8187522	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	3.51	CHEMBL4901	Homo sapiens	Inhibition	%	3.51
	8187670	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	2.36	CHEMBL4901	Homo sapiens	Inhibition	%	2.36
	8188023	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-4.69	CHEMBL4901	Homo sapiens	Inhibition	%	-4.69
	8188166	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.51	CHEMBL4901	Homo sapiens	Inhibition	%	3.51
	8188390	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	2.43	CHEMBL4901	Homo sapiens	Inhibition	%	2.43
	8188525	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-0.24	CHEMBL4901	Homo sapiens	Inhibition	%	-0.24
	8188799	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	7.71	CHEMBL4901	Homo sapiens	Inhibition	%	7.71
	8189171	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	2.7	CHEMBL4901	Homo sapiens	Inhibition	%	2.7
	8189327	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	16.23	CHEMBL4901	Homo sapiens	Inhibition	%	16.23
	8189700	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	2.99	CHEMBL4901	Homo sapiens	Inhibition	%	2.99
	8189832	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	4.21	CHEMBL4901	Homo sapiens	Inhibition	%	4.21
	8190188	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	8.03	CHEMBL4901	Homo sapiens	Inhibition	%	8.03
	8190552	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	7.22	CHEMBL4901	Homo sapiens	Inhibition	%	7.22
	8190689	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.59	CHEMBL4901	Homo sapiens	Inhibition	%	3.59
	8191077	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	6.05	CHEMBL4901	Homo sapiens	Inhibition	%	6.05
	8191215	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	5.05	CHEMBL4901	Homo sapiens	Inhibition	%	5.05
	8191535	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	9.99	CHEMBL4901	Homo sapiens	Inhibition	%	9.99
	8191881	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.86	CHEMBL4901	Homo sapiens	Inhibition	%	5.86
	8192030	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	3.73	CHEMBL4901	Homo sapiens	Inhibition	%	3.73
	8192254	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.63	CHEMBL4901	Homo sapiens	Inhibition	%	2.63
	8192383	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	-0.7	CHEMBL4901	Homo sapiens	Inhibition	%	-0.7
	8192751	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	5.82	CHEMBL4901	Homo sapiens	Inhibition	%	5.82
	8192887	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-2.08	CHEMBL4901	Homo sapiens	Inhibition	%	-2.08
	8193159	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.53	CHEMBL4901	Homo sapiens	Inhibition	%	4.53
	8193528	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	4.2	CHEMBL4901	Homo sapiens	Inhibition	%	4.2
	8193685	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	5.46	CHEMBL4901	Homo sapiens	Inhibition	%	5.46
	8193909	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	2.58	CHEMBL4901	Homo sapiens	Inhibition	%	2.58
	8194058	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-2.28	CHEMBL4901	Homo sapiens	Inhibition	%	-2.28
	8194189	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	0.73	CHEMBL4901	Homo sapiens	Inhibition	%	0.73
	8194413	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	6.58	CHEMBL4901	Homo sapiens	Inhibition	%	6.58
	8194544	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	5.59	CHEMBL4901	Homo sapiens	Inhibition	%	5.59
	8194911	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	21.09	CHEMBL4901	Homo sapiens	Inhibition	%	21.09
	8195044	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.67	CHEMBL4901	Homo sapiens	Inhibition	%	4.67
	8195268	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.0	CHEMBL4901	Homo sapiens	Inhibition	%	2.0
	8195432	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	4.56	CHEMBL4901	Homo sapiens	Inhibition	%	4.56
	8195571	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	1.99	CHEMBL4901	Homo sapiens	Inhibition	%	1.99
	8195795	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	5.72	CHEMBL4901	Homo sapiens	Inhibition	%	5.72
	8195893	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.81	CHEMBL4901	Homo sapiens	Inhibition	%	3.81
	8196234	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	3.69	CHEMBL4901	Homo sapiens	Inhibition	%	3.69
	8196608	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	6.49	CHEMBL4901	Homo sapiens	Inhibition	%	6.49
	8196736	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.39	CHEMBL4901	Homo sapiens	Inhibition	%	0.39
	8197101	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	4.91	CHEMBL4901	Homo sapiens	Inhibition	%	4.91
	8197238	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.9	CHEMBL4901	Homo sapiens	Inhibition	%	2.9
	8197462	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.21	CHEMBL4901	Homo sapiens	Inhibition	%	1.21
	8197513	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	5.88	CHEMBL4901	Homo sapiens	Inhibition	%	5.88
	8197737	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	5.99	CHEMBL4901	Homo sapiens	Inhibition	%	5.99
	8197877	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.15	CHEMBL4901	Homo sapiens	Inhibition	%	2.15
	8198258	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.13	CHEMBL4901	Homo sapiens	Inhibition	%	2.13
	8198396	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-3.63	CHEMBL4901	Homo sapiens	Inhibition	%	-3.63
	8198750	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	2.9	CHEMBL4901	Homo sapiens	Inhibition	%	2.9
	8198881	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	7.43	CHEMBL4901	Homo sapiens	Inhibition	%	7.43
	8199105	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	6.04	CHEMBL4901	Homo sapiens	Inhibition	%	6.04
	8199253	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.07	CHEMBL4901	Homo sapiens	Inhibition	%	4.07
	8199611	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.96	CHEMBL4901	Homo sapiens	Inhibition	%	4.96
	8199774	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	5.53	CHEMBL4901	Homo sapiens	Inhibition	%	5.53
	8200136	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.87	CHEMBL4901	Homo sapiens	Inhibition	%	3.87
	8200240	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.31	CHEMBL4901	Homo sapiens	Inhibition	%	2.31
	8200464	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	4.87	CHEMBL4901	Homo sapiens	Inhibition	%	4.87
	8200579	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	6.08	CHEMBL4901	Homo sapiens	Inhibition	%	6.08
	8200953	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	11.45	CHEMBL4901	Homo sapiens	Inhibition	%	11.45
	8201083	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-3.17	CHEMBL4901	Homo sapiens	Inhibition	%	-3.17
	8201307	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-3.49	CHEMBL4901	Homo sapiens	Inhibition	%	-3.49
	8201442	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	5.73	CHEMBL4901	Homo sapiens	Inhibition	%	5.73
	8201799	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	4.06	CHEMBL4901	Homo sapiens	Inhibition	%	4.06
	8202078	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	6.25	CHEMBL4901	Homo sapiens	Inhibition	%	6.25
	8202218	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.6	CHEMBL4901	Homo sapiens	Inhibition	%	1.6
	8202609	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-1.28	CHEMBL4901	Homo sapiens	Inhibition	%	-1.28
	8202734	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	7.2	CHEMBL4901	Homo sapiens	Inhibition	%	7.2
	8202958	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	4.44	CHEMBL4901	Homo sapiens	Inhibition	%	4.44
	8203088	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	6.33	CHEMBL4901	Homo sapiens	Inhibition	%	6.33
	8203443	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	3.38	CHEMBL4901	Homo sapiens	Inhibition	%	3.38
	8203589	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.22	CHEMBL4901	Homo sapiens	Inhibition	%	4.22
	8203947	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	3.65	CHEMBL4901	Homo sapiens	Inhibition	%	3.65
	8204113	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	17.41	CHEMBL4901	Homo sapiens	Inhibition	%	17.41
	8204337	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	49.22	CHEMBL4901	Homo sapiens	Inhibition	%	49.22
	8204474	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	18.07	CHEMBL4901	Homo sapiens	Inhibition	%	18.07
	8204803	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	5.92	CHEMBL4901	Homo sapiens	Inhibition	%	5.92
	8204918	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	3.99	CHEMBL4901	Homo sapiens	Inhibition	%	3.99
	8205142	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	5.19	CHEMBL4901	Homo sapiens	Inhibition	%	5.19
	8205291	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	2.88	CHEMBL4901	Homo sapiens	Inhibition	%	2.88
	8205651	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.72	CHEMBL4901	Homo sapiens	Inhibition	%	1.72
	8205790	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.29	CHEMBL4901	Homo sapiens	Inhibition	%	3.29
	8206146	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	14.63	CHEMBL4901	Homo sapiens	Inhibition	%	14.63
	8206422	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.96	CHEMBL4901	Homo sapiens	Inhibition	%	3.96
	8206565	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.61	CHEMBL4901	Homo sapiens	Inhibition	%	-1.61
	8206789	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-4.71	CHEMBL4901	Homo sapiens	Inhibition	%	-4.71
	8206969	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	5.3	CHEMBL4901	Homo sapiens	Inhibition	%	5.3
	8207319	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.95	CHEMBL4901	Homo sapiens	Inhibition	%	5.95
	8207449	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.76	CHEMBL4901	Homo sapiens	Inhibition	%	3.76
	8207805	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	0.55	CHEMBL4901	Homo sapiens	Inhibition	%	0.55
	8207950	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	6.96	CHEMBL4901	Homo sapiens	Inhibition	%	6.96
	8208174	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.37	CHEMBL4901	Homo sapiens	Inhibition	%	3.37
	8208306	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.76	CHEMBL4901	Homo sapiens	Inhibition	%	4.76
	8208696	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	4.2	CHEMBL4901	Homo sapiens	Inhibition	%	4.2
	8208829	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	53.28	CHEMBL4901	Homo sapiens	Inhibition	%	53.28
	8209158	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	2.15	CHEMBL4901	Homo sapiens	Inhibition	%	2.15
	8209498	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.99	CHEMBL4901	Homo sapiens	Inhibition	%	2.99
	8209648	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.96	CHEMBL4901	Homo sapiens	Inhibition	%	3.96
	8210008	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.82	CHEMBL4901	Homo sapiens	Inhibition	%	2.82
	8210149	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.23	CHEMBL4901	Homo sapiens	Inhibition	%	4.23
	8210373	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	3.77	CHEMBL4901	Homo sapiens	Inhibition	%	3.77
	8210509	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.11	CHEMBL4901	Homo sapiens	Inhibition	%	-2.11
	8210768	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.15	CHEMBL4901	Homo sapiens	Inhibition	%	1.15
	8211136	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	7.34	CHEMBL4901	Homo sapiens	Inhibition	%	7.34
	8211306	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.05	CHEMBL4901	Homo sapiens	Inhibition	%	2.05
	8211653	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.53	CHEMBL4901	Homo sapiens	Inhibition	%	5.53
	8211782	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	9.61	CHEMBL4901	Homo sapiens	Inhibition	%	9.61
	8212006	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	5.92	CHEMBL4901	Homo sapiens	Inhibition	%	5.92
	8212138	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	6.23	CHEMBL4901	Homo sapiens	Inhibition	%	6.23
	8212503	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	5.69	CHEMBL4901	Homo sapiens	Inhibition	%	5.69
	8212636	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.2	CHEMBL4901	Homo sapiens	Inhibition	%	2.2
	8212860	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.24	CHEMBL4901	Homo sapiens	Inhibition	%	4.24
	8213030	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	4.54	CHEMBL4901	Homo sapiens	Inhibition	%	4.54
	8213159	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.08	CHEMBL4901	Homo sapiens	Inhibition	%	5.08
	8213383	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	6.13	CHEMBL4901	Homo sapiens	Inhibition	%	6.13
	8213487	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.93	CHEMBL4901	Homo sapiens	Inhibition	%	0.93
	8213824	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.23	CHEMBL4901	Homo sapiens	Inhibition	%	3.23
	8213971	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	4.28	CHEMBL4901	Homo sapiens	Inhibition	%	4.28
	8214195	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	4.38	CHEMBL4901	Homo sapiens	Inhibition	%	4.38
	8214332	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	3.78	CHEMBL4901	Homo sapiens	Inhibition	%	3.78
	8214690	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	0.29	CHEMBL4901	Homo sapiens	Inhibition	%	0.29
	8214842	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-3.61	CHEMBL4901	Homo sapiens	Inhibition	%	-3.61
	8215093	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-1.34	CHEMBL4901	Homo sapiens	Inhibition	%	-1.34
	8215317	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	5.73	CHEMBL4901	Homo sapiens	Inhibition	%	5.73
	8215470	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	6.47	CHEMBL4901	Homo sapiens	Inhibition	%	6.47
	8215634	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	6.61	CHEMBL4901	Homo sapiens	Inhibition	%	6.61
	8215858	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	5.15	CHEMBL4901	Homo sapiens	Inhibition	%	5.15
	8215977	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	0.85	CHEMBL4901	Homo sapiens	Inhibition	%	0.85
	8216320	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	7.23	CHEMBL4901	Homo sapiens	Inhibition	%	7.23
	8216456	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	4.28	CHEMBL4901	Homo sapiens	Inhibition	%	4.28
	8216818	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.87	CHEMBL4901	Homo sapiens	Inhibition	%	1.87
	8217176	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	5.58	CHEMBL4901	Homo sapiens	Inhibition	%	5.58
	8217350	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	2.67	CHEMBL4901	Homo sapiens	Inhibition	%	2.67
	8217705	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	5.99	CHEMBL4901	Homo sapiens	Inhibition	%	5.99
	8217806	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-6.22	CHEMBL4901	Homo sapiens	Inhibition	%	-6.22
	8218030	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.9	CHEMBL4901	Homo sapiens	Inhibition	%	-1.9
	8218145	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.83	CHEMBL4901	Homo sapiens	Inhibition	%	3.83
	8218496	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	5.98	CHEMBL4901	Homo sapiens	Inhibition	%	5.98
	8218639	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	5.92	CHEMBL4901	Homo sapiens	Inhibition	%	5.92
	8218994	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	-0.39	CHEMBL4901	Homo sapiens	Inhibition	%	-0.39
	8219154	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-5.09	CHEMBL4901	Homo sapiens	Inhibition	%	-5.09
	8219378	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-7.2	CHEMBL4901	Homo sapiens	Inhibition	%	-7.2
	8219628	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.41	CHEMBL4901	Homo sapiens	Inhibition	%	3.41
	8219789	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	6.18	CHEMBL4901	Homo sapiens	Inhibition	%	6.18
	8220182	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	6.57	CHEMBL4901	Homo sapiens	Inhibition	%	6.57
	8220311	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-0.23	CHEMBL4901	Homo sapiens	Inhibition	%	-0.23
	8220649	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.9	CHEMBL4901	Homo sapiens	Inhibition	%	4.9
	8220787	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	7.65	CHEMBL4901	Homo sapiens	Inhibition	%	7.65
	8221011	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	3.73	CHEMBL4901	Homo sapiens	Inhibition	%	3.73
	8221147	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.12	CHEMBL4901	Homo sapiens	Inhibition	%	1.12
	8221504	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.69	CHEMBL4901	Homo sapiens	Inhibition	%	3.69
	8221669	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.66	CHEMBL4901	Homo sapiens	Inhibition	%	0.66
	8222024	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	4.4	CHEMBL4901	Homo sapiens	Inhibition	%	4.4
	8222346	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.26	CHEMBL4901	Homo sapiens	Inhibition	%	3.26
	8222480	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.2	CHEMBL4901	Homo sapiens	Inhibition	%	3.2
	8222822	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	7.32	CHEMBL4901	Homo sapiens	Inhibition	%	7.32
	8222966	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	92.66	CHEMBL4901	Homo sapiens	Inhibition	%	92.66
	8223190	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	99.73	CHEMBL4901	Homo sapiens	Inhibition	%	99.73
	8223319	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	5.05	CHEMBL4901	Homo sapiens	Inhibition	%	5.05
	8223704	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-1.18	CHEMBL4901	Homo sapiens	Inhibition	%	-1.18
	8223954	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	7.13	CHEMBL4901	Homo sapiens	Inhibition	%	7.13
	8224116	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	5.65	CHEMBL4901	Homo sapiens	Inhibition	%	5.65
	8224340	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	1.72	CHEMBL4901	Homo sapiens	Inhibition	%	1.72
	8224510	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.99	CHEMBL4901	Homo sapiens	Inhibition	%	4.99
	8224645	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.65	CHEMBL4901	Homo sapiens	Inhibition	%	4.65
	8224869	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.98	CHEMBL4901	Homo sapiens	Inhibition	%	4.98
	8224983	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	5.62	CHEMBL4901	Homo sapiens	Inhibition	%	5.62
	8225341	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	8.13	CHEMBL4901	Homo sapiens	Inhibition	%	8.13
	8225479	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-2.08	CHEMBL4901	Homo sapiens	Inhibition	%	-2.08
	8225703	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	4.03	CHEMBL4901	Homo sapiens	Inhibition	%	4.03
	8225838	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	6.24	CHEMBL4901	Homo sapiens	Inhibition	%	6.24
	8225996	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.29	CHEMBL4901	Homo sapiens	Inhibition	%	1.29
	8226220	CHEMBL1962277	GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.97	CHEMBL4901	Homo sapiens	Inhibition	%	2.97
	8226345	CHEMBL1962276	GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	5.26	CHEMBL4901	Homo sapiens	Inhibition	%	5.26
	10838577	CHEMBL2014150	Inhibition of EPHB3 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	0.0	CHEMBL4901	Homo sapiens	INH	%	0.0
	10839604	CHEMBL2015012	Inhibition of EPH-B3 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	26.0	CHEMBL4901	Homo sapiens	Activity	%	26.0
	10840435	CHEMBL2015955	Inhibition of EPH-B3 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	80.0	CHEMBL4901	Homo sapiens	Activity	%	80.0
	12046294	CHEMBL2156531	Inhibition of EphB3 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-0.3	CHEMBL4901	Homo sapiens	INH	%	-0.3
	12170814	CHEMBL2210337	Inhibition of EPH-B3 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	121.0	CHEMBL4901	Homo sapiens	Activity	%	121.0
	12172115	CHEMBL2213942	Inhibition of EPH-B3 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	113.0	CHEMBL4901	Homo sapiens	Activity	%	113.0
	12173630	CHEMBL2214006	Inhibition of EPHB3 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	67.0	CHEMBL4901	Homo sapiens	Activity	%	67.0
	12228053	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	96.0	CHEMBL4901	Homo sapiens	Residual Activity	%	96.0
	12228054	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	113.0	CHEMBL4901	Homo sapiens	Residual Activity	%	113.0
	12228055	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	90.0	CHEMBL4901	Homo sapiens	Residual Activity	%	90.0
	12228056	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	106.0	CHEMBL4901	Homo sapiens	Residual Activity	%	106.0
	12228057	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	95.0	CHEMBL4901	Homo sapiens	Residual Activity	%	95.0
	12228058	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	109.0	CHEMBL4901	Homo sapiens	Residual Activity	%	109.0
	12228059	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	100.0	CHEMBL4901	Homo sapiens	Residual Activity	%	100.0
	12228060	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	94.0	CHEMBL4901	Homo sapiens	Residual Activity	%	94.0
	12228061	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	107.0	CHEMBL4901	Homo sapiens	Residual Activity	%	107.0
	12228062	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	110.0	CHEMBL4901	Homo sapiens	Residual Activity	%	110.0
	12228063	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	115.0	CHEMBL4901	Homo sapiens	Residual Activity	%	115.0
	12228064	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	110.0	CHEMBL4901	Homo sapiens	Residual Activity	%	110.0
	12228065	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	111.0	CHEMBL4901	Homo sapiens	Residual Activity	%	111.0
	12228066	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	112.0	CHEMBL4901	Homo sapiens	Residual Activity	%	112.0
	12228067	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	113.0	CHEMBL4901	Homo sapiens	Residual Activity	%	113.0
	12228068	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	111.0	CHEMBL4901	Homo sapiens	Residual Activity	%	111.0
	12228069	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	131.0	CHEMBL4901	Homo sapiens	Residual Activity	%	131.0
	12228070	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	126.0	CHEMBL4901	Homo sapiens	Residual Activity	%	126.0
	12228071	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	110.0	CHEMBL4901	Homo sapiens	Residual Activity	%	110.0
	12228072	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	105.0	CHEMBL4901	Homo sapiens	Residual Activity	%	105.0
	12228073	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	102.0	CHEMBL4901	Homo sapiens	Residual Activity	%	102.0
	12228074	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	100.0	CHEMBL4901	Homo sapiens	Residual Activity	%	100.0
	12228075	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	117.0	CHEMBL4901	Homo sapiens	Residual Activity	%	117.0
	12228076	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	113.0	CHEMBL4901	Homo sapiens	Residual Activity	%	113.0
	12228077	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	112.0	CHEMBL4901	Homo sapiens	Residual Activity	%	112.0
	12228078	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	108.0	CHEMBL4901	Homo sapiens	Residual Activity	%	108.0
	12228079	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	105.0	CHEMBL4901	Homo sapiens	Residual Activity	%	105.0
	12228080	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	99.0	CHEMBL4901	Homo sapiens	Residual Activity	%	99.0
	12228081	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	110.0	CHEMBL4901	Homo sapiens	Residual Activity	%	110.0
	12228082	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	114.0	CHEMBL4901	Homo sapiens	Residual Activity	%	114.0
	12228083	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	102.0	CHEMBL4901	Homo sapiens	Residual Activity	%	102.0
	12228084	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	123.0	CHEMBL4901	Homo sapiens	Residual Activity	%	123.0
	12228085	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	123.0	CHEMBL4901	Homo sapiens	Residual Activity	%	123.0
	12228086	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	110.0	CHEMBL4901	Homo sapiens	Residual Activity	%	110.0
	12228087	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	114.0	CHEMBL4901	Homo sapiens	Residual Activity	%	114.0
	12228088	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	112.0	CHEMBL4901	Homo sapiens	Residual Activity	%	112.0
	12228089	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	112.0	CHEMBL4901	Homo sapiens	Residual Activity	%	112.0
	12228090	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	100.0	CHEMBL4901	Homo sapiens	Residual Activity	%	100.0
	12228091	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	119.0	CHEMBL4901	Homo sapiens	Residual Activity	%	119.0
	12228092	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	114.0	CHEMBL4901	Homo sapiens	Residual Activity	%	114.0
	12228093	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	106.0	CHEMBL4901	Homo sapiens	Residual Activity	%	106.0
	12228094	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	105.0	CHEMBL4901	Homo sapiens	Residual Activity	%	105.0
	12228095	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	105.0	CHEMBL4901	Homo sapiens	Residual Activity	%	105.0
	12228096	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	101.0	CHEMBL4901	Homo sapiens	Residual Activity	%	101.0
	12228097	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	116.0	CHEMBL4901	Homo sapiens	Residual Activity	%	116.0
	12228098	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	106.0	CHEMBL4901	Homo sapiens	Residual Activity	%	106.0
	12228099	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	102.0	CHEMBL4901	Homo sapiens	Residual Activity	%	102.0
	12228100	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	113.0	CHEMBL4901	Homo sapiens	Residual Activity	%	113.0
	12228101	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	108.0	CHEMBL4901	Homo sapiens	Residual Activity	%	108.0
	12228102	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	116.0	CHEMBL4901	Homo sapiens	Residual Activity	%	116.0
	12228103	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	111.0	CHEMBL4901	Homo sapiens	Residual Activity	%	111.0
	12228104	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	104.0	CHEMBL4901	Homo sapiens	Residual Activity	%	104.0
	12228105	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	120.0	CHEMBL4901	Homo sapiens	Residual Activity	%	120.0
	12228106	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	118.0	CHEMBL4901	Homo sapiens	Residual Activity	%	118.0
	12228107	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	111.0	CHEMBL4901	Homo sapiens	Residual Activity	%	111.0
	12228108	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	115.0	CHEMBL4901	Homo sapiens	Residual Activity	%	115.0
	12228109	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	119.0	CHEMBL4901	Homo sapiens	Residual Activity	%	119.0
	12228110	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	112.0	CHEMBL4901	Homo sapiens	Residual Activity	%	112.0
	12228111	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	93.0	CHEMBL4901	Homo sapiens	Residual Activity	%	93.0
	12228112	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	108.0	CHEMBL4901	Homo sapiens	Residual Activity	%	108.0
	12228113	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	113.0	CHEMBL4901	Homo sapiens	Residual Activity	%	113.0
	12228114	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	119.0	CHEMBL4901	Homo sapiens	Residual Activity	%	119.0
	12228115	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	118.0	CHEMBL4901	Homo sapiens	Residual Activity	%	118.0
	12228116	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	115.0	CHEMBL4901	Homo sapiens	Residual Activity	%	115.0
	12228117	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	95.0	CHEMBL4901	Homo sapiens	Residual Activity	%	95.0
	12228118	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	108.0	CHEMBL4901	Homo sapiens	Residual Activity	%	108.0
	12228119	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	111.0	CHEMBL4901	Homo sapiens	Residual Activity	%	111.0
	12228120	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	109.0	CHEMBL4901	Homo sapiens	Residual Activity	%	109.0
	12228121	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	113.0	CHEMBL4901	Homo sapiens	Residual Activity	%	113.0
	12228122	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	120.0	CHEMBL4901	Homo sapiens	Residual Activity	%	120.0
	12228123	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	106.0	CHEMBL4901	Homo sapiens	Residual Activity	%	106.0
	12228124	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	106.0	CHEMBL4901	Homo sapiens	Residual Activity	%	106.0
	12228125	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	108.0	CHEMBL4901	Homo sapiens	Residual Activity	%	108.0
	12228126	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	117.0	CHEMBL4901	Homo sapiens	Residual Activity	%	117.0
	12228127	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	112.0	CHEMBL4901	Homo sapiens	Residual Activity	%	112.0
	12228128	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	112.0	CHEMBL4901	Homo sapiens	Residual Activity	%	112.0
	12228129	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	125.0	CHEMBL4901	Homo sapiens	Residual Activity	%	125.0
	12228130	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	129.0	CHEMBL4901	Homo sapiens	Residual Activity	%	129.0
	12228131	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	132.0	CHEMBL4901	Homo sapiens	Residual Activity	%	132.0
	12228132	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	119.0	CHEMBL4901	Homo sapiens	Residual Activity	%	119.0
	12228133	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	116.0	CHEMBL4901	Homo sapiens	Residual Activity	%	116.0
	12228134	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	115.0	CHEMBL4901	Homo sapiens	Residual Activity	%	115.0
	12228135	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	107.0	CHEMBL4901	Homo sapiens	Residual Activity	%	107.0
	12228136	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	111.0	CHEMBL4901	Homo sapiens	Residual Activity	%	111.0
	12228137	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	120.0	CHEMBL4901	Homo sapiens	Residual Activity	%	120.0
	12228138	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	109.0	CHEMBL4901	Homo sapiens	Residual Activity	%	109.0
	12228139	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	108.0	CHEMBL4901	Homo sapiens	Residual Activity	%	108.0
	12228140	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	114.0	CHEMBL4901	Homo sapiens	Residual Activity	%	114.0
	12228141	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	119.0	CHEMBL4901	Homo sapiens	Residual Activity	%	119.0
	12228142	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	105.0	CHEMBL4901	Homo sapiens	Residual Activity	%	105.0
	12228143	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	114.0	CHEMBL4901	Homo sapiens	Residual Activity	%	114.0
	12228144	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	101.0	CHEMBL4901	Homo sapiens	Residual Activity	%	101.0
	12228145	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	111.0	CHEMBL4901	Homo sapiens	Residual Activity	%	111.0
	12228146	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	103.0	CHEMBL4901	Homo sapiens	Residual Activity	%	103.0
	12228147	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	83.0	CHEMBL4901	Homo sapiens	Residual Activity	%	83.0
	12228148	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	107.0	CHEMBL4901	Homo sapiens	Residual Activity	%	107.0
	12228149	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	104.0	CHEMBL4901	Homo sapiens	Residual Activity	%	104.0
	12228150	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	118.0	CHEMBL4901	Homo sapiens	Residual Activity	%	118.0
	12228151	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	104.0	CHEMBL4901	Homo sapiens	Residual Activity	%	104.0
	12228152	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	109.0	CHEMBL4901	Homo sapiens	Residual Activity	%	109.0
	12228153	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	121.0	CHEMBL4901	Homo sapiens	Residual Activity	%	121.0
	12228154	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	110.0	CHEMBL4901	Homo sapiens	Residual Activity	%	110.0
	12228155	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	107.0	CHEMBL4901	Homo sapiens	Residual Activity	%	107.0
	12228156	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	118.0	CHEMBL4901	Homo sapiens	Residual Activity	%	118.0
	12228157	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	124.0	CHEMBL4901	Homo sapiens	Residual Activity	%	124.0
	12228158	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	121.0	CHEMBL4901	Homo sapiens	Residual Activity	%	121.0
	12228159	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	110.0	CHEMBL4901	Homo sapiens	Residual Activity	%	110.0
	12228160	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	100.0	CHEMBL4901	Homo sapiens	Residual Activity	%	100.0
	12228161	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	124.0	CHEMBL4901	Homo sapiens	Residual Activity	%	124.0
	12228162	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	114.0	CHEMBL4901	Homo sapiens	Residual Activity	%	114.0
	12228163	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	126.0	CHEMBL4901	Homo sapiens	Residual Activity	%	126.0
	12228164	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	126.0	CHEMBL4901	Homo sapiens	Residual Activity	%	126.0
	12228165	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	106.0	CHEMBL4901	Homo sapiens	Residual Activity	%	106.0
	12228166	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	107.0	CHEMBL4901	Homo sapiens	Residual Activity	%	107.0
	12228167	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	102.0	CHEMBL4901	Homo sapiens	Residual Activity	%	102.0
	12228168	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	104.0	CHEMBL4901	Homo sapiens	Residual Activity	%	104.0
	12228169	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	117.0	CHEMBL4901	Homo sapiens	Residual Activity	%	117.0
	12228170	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	112.0	CHEMBL4901	Homo sapiens	Residual Activity	%	112.0
	12228171	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	117.0	CHEMBL4901	Homo sapiens	Residual Activity	%	117.0
	12228172	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	113.0	CHEMBL4901	Homo sapiens	Residual Activity	%	113.0
	12228173	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	110.0	CHEMBL4901	Homo sapiens	Residual Activity	%	110.0
	12228174	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	110.0	CHEMBL4901	Homo sapiens	Residual Activity	%	110.0
	12228175	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	108.0	CHEMBL4901	Homo sapiens	Residual Activity	%	108.0
	12228176	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	104.0	CHEMBL4901	Homo sapiens	Residual Activity	%	104.0
	12228177	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	117.0	CHEMBL4901	Homo sapiens	Residual Activity	%	117.0
	12228178	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	114.0	CHEMBL4901	Homo sapiens	Residual Activity	%	114.0
	12228179	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	77.0	CHEMBL4901	Homo sapiens	Residual Activity	%	77.0
	12228180	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	88.0	CHEMBL4901	Homo sapiens	Residual Activity	%	88.0
	12228181	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	121.0	CHEMBL4901	Homo sapiens	Residual Activity	%	121.0
	12228182	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	109.0	CHEMBL4901	Homo sapiens	Residual Activity	%	109.0
	12228183	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	113.0	CHEMBL4901	Homo sapiens	Residual Activity	%	113.0
	12228184	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	117.0	CHEMBL4901	Homo sapiens	Residual Activity	%	117.0
	12228185	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	111.0	CHEMBL4901	Homo sapiens	Residual Activity	%	111.0
	12228186	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	110.0	CHEMBL4901	Homo sapiens	Residual Activity	%	110.0
	12228187	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	105.0	CHEMBL4901	Homo sapiens	Residual Activity	%	105.0
	12228188	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	92.0	CHEMBL4901	Homo sapiens	Residual Activity	%	92.0
	12228189	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	107.0	CHEMBL4901	Homo sapiens	Residual Activity	%	107.0
	12228190	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	102.0	CHEMBL4901	Homo sapiens	Residual Activity	%	102.0
	12228191	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	100.0	CHEMBL4901	Homo sapiens	Residual Activity	%	100.0
	12228192	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	104.0	CHEMBL4901	Homo sapiens	Residual Activity	%	104.0
	12228193	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	105.0	CHEMBL4901	Homo sapiens	Residual Activity	%	105.0
	12228194	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	101.0	CHEMBL4901	Homo sapiens	Residual Activity	%	101.0
	12228195	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	98.0	CHEMBL4901	Homo sapiens	Residual Activity	%	98.0
	12228196	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	118.0	CHEMBL4901	Homo sapiens	Residual Activity	%	118.0
	12228197	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	117.0	CHEMBL4901	Homo sapiens	Residual Activity	%	117.0
	12228198	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	120.0	CHEMBL4901	Homo sapiens	Residual Activity	%	120.0
	12228199	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	107.0	CHEMBL4901	Homo sapiens	Residual Activity	%	107.0
	12228200	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	141.0	CHEMBL4901	Homo sapiens	Residual Activity	%	141.0
	12228201	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	123.0	CHEMBL4901	Homo sapiens	Residual Activity	%	123.0
	12228202	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	110.0	CHEMBL4901	Homo sapiens	Residual Activity	%	110.0
	12228203	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	108.0	CHEMBL4901	Homo sapiens	Residual Activity	%	108.0
	12228204	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	107.0	CHEMBL4901	Homo sapiens	Residual Activity	%	107.0
	12228205	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	97.0	CHEMBL4901	Homo sapiens	Residual Activity	%	97.0
	12228206	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	94.0	CHEMBL4901	Homo sapiens	Residual Activity	%	94.0
	12228207	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	116.0	CHEMBL4901	Homo sapiens	Residual Activity	%	116.0
	12228208	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	105.0	CHEMBL4901	Homo sapiens	Residual Activity	%	105.0
	12228209	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	95.0	CHEMBL4901	Homo sapiens	Residual Activity	%	95.0
	12228210	CHEMBL2219054	Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	110.0	CHEMBL4901	Homo sapiens	Residual Activity	%	110.0
	12228211	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	121.0	CHEMBL4901	Homo sapiens	Residual Activity	%	121.0
	12228212	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	115.0	CHEMBL4901	Homo sapiens	Residual Activity	%	115.0
	12228213	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	100.0	CHEMBL4901	Homo sapiens	Residual Activity	%	100.0
	12228214	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	84.0	CHEMBL4901	Homo sapiens	Residual Activity	%	84.0
	12228215	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	120.0	CHEMBL4901	Homo sapiens	Residual Activity	%	120.0
	12228216	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	116.0	CHEMBL4901	Homo sapiens	Residual Activity	%	116.0
	12228217	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	117.0	CHEMBL4901	Homo sapiens	Residual Activity	%	117.0
	12228218	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	121.0	CHEMBL4901	Homo sapiens	Residual Activity	%	121.0
	12228219	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	124.0	CHEMBL4901	Homo sapiens	Residual Activity	%	124.0
	12228220	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	123.0	CHEMBL4901	Homo sapiens	Residual Activity	%	123.0
	12228221	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	102.0	CHEMBL4901	Homo sapiens	Residual Activity	%	102.0
	12228222	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	108.0	CHEMBL4901	Homo sapiens	Residual Activity	%	108.0
	12228223	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	120.0	CHEMBL4901	Homo sapiens	Residual Activity	%	120.0
	12228224	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	12.0	CHEMBL4901	Homo sapiens	Residual Activity	%	12.0
	12228225	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	111.0	CHEMBL4901	Homo sapiens	Residual Activity	%	111.0
	12228226	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	116.0	CHEMBL4901	Homo sapiens	Residual Activity	%	116.0
	12228227	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	160.0	CHEMBL4901	Homo sapiens	Residual Activity	%	160.0
	12228228	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	133.0	CHEMBL4901	Homo sapiens	Residual Activity	%	133.0
	12228229	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	122.0	CHEMBL4901	Homo sapiens	Residual Activity	%	122.0
	12228230	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	112.0	CHEMBL4901	Homo sapiens	Residual Activity	%	112.0
	12228231	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	120.0	CHEMBL4901	Homo sapiens	Residual Activity	%	120.0
	12230769	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	105.0	CHEMBL4901	Homo sapiens	Residual Activity	%	105.0
	12230770	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	111.0	CHEMBL4901	Homo sapiens	Residual Activity	%	111.0
	12230771	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	125.0	CHEMBL4901	Homo sapiens	Residual Activity	%	125.0
	12230772	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	121.0	CHEMBL4901	Homo sapiens	Residual Activity	%	121.0
	12230773	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	126.0	CHEMBL4901	Homo sapiens	Residual Activity	%	126.0
	12230774	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	126.0	CHEMBL4901	Homo sapiens	Residual Activity	%	126.0
	12230775	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	123.0	CHEMBL4901	Homo sapiens	Residual Activity	%	123.0
	12230776	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	146.0	CHEMBL4901	Homo sapiens	Residual Activity	%	146.0
	12230777	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	148.0	CHEMBL4901	Homo sapiens	Residual Activity	%	148.0
	12230778	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	137.0	CHEMBL4901	Homo sapiens	Residual Activity	%	137.0
	12230779	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	84.0	CHEMBL4901	Homo sapiens	Residual Activity	%	84.0
	12230780	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	105.0	CHEMBL4901	Homo sapiens	Residual Activity	%	105.0
	12230781	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	116.0	CHEMBL4901	Homo sapiens	Residual Activity	%	116.0
	12230782	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	110.0	CHEMBL4901	Homo sapiens	Residual Activity	%	110.0
	12230783	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	94.0	CHEMBL4901	Homo sapiens	Residual Activity	%	94.0
	12230784	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	95.0	CHEMBL4901	Homo sapiens	Residual Activity	%	95.0
	12230785	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	57.0	CHEMBL4901	Homo sapiens	Residual Activity	%	57.0
	12230786	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	131.0	CHEMBL4901	Homo sapiens	Residual Activity	%	131.0
	12230787	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	117.0	CHEMBL4901	Homo sapiens	Residual Activity	%	117.0
	12230788	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	132.0	CHEMBL4901	Homo sapiens	Residual Activity	%	132.0
	12230789	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	107.0	CHEMBL4901	Homo sapiens	Residual Activity	%	107.0
	12230790	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	118.0	CHEMBL4901	Homo sapiens	Residual Activity	%	118.0
	12230791	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	121.0	CHEMBL4901	Homo sapiens	Residual Activity	%	121.0
	12230792	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	129.0	CHEMBL4901	Homo sapiens	Residual Activity	%	129.0
	12230793	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	112.0	CHEMBL4901	Homo sapiens	Residual Activity	%	112.0
	12230794	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	128.0	CHEMBL4901	Homo sapiens	Residual Activity	%	128.0
	12230795	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	120.0	CHEMBL4901	Homo sapiens	Residual Activity	%	120.0
	12230796	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	133.0	CHEMBL4901	Homo sapiens	Residual Activity	%	133.0
	12230797	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	123.0	CHEMBL4901	Homo sapiens	Residual Activity	%	123.0
	12230798	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	124.0	CHEMBL4901	Homo sapiens	Residual Activity	%	124.0
	12230799	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	117.0	CHEMBL4901	Homo sapiens	Residual Activity	%	117.0
	12230800	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	131.0	CHEMBL4901	Homo sapiens	Residual Activity	%	131.0
	12230801	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	128.0	CHEMBL4901	Homo sapiens	Residual Activity	%	128.0
	12230802	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	133.0	CHEMBL4901	Homo sapiens	Residual Activity	%	133.0
	12230803	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	125.0	CHEMBL4901	Homo sapiens	Residual Activity	%	125.0
	12230804	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	126.0	CHEMBL4901	Homo sapiens	Residual Activity	%	126.0
	12230805	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	107.0	CHEMBL4901	Homo sapiens	Residual Activity	%	107.0
	12230806	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	100.0	CHEMBL4901	Homo sapiens	Residual Activity	%	100.0
	12230807	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	115.0	CHEMBL4901	Homo sapiens	Residual Activity	%	115.0
	12230808	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	115.0	CHEMBL4901	Homo sapiens	Residual Activity	%	115.0
	12230809	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	130.0	CHEMBL4901	Homo sapiens	Residual Activity	%	130.0
	12230810	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	106.0	CHEMBL4901	Homo sapiens	Residual Activity	%	106.0
	12230811	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	104.0	CHEMBL4901	Homo sapiens	Residual Activity	%	104.0
	12230812	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	117.0	CHEMBL4901	Homo sapiens	Residual Activity	%	117.0
	12230813	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	123.0	CHEMBL4901	Homo sapiens	Residual Activity	%	123.0
	12230814	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	102.0	CHEMBL4901	Homo sapiens	Residual Activity	%	102.0
	12230815	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	103.0	CHEMBL4901	Homo sapiens	Residual Activity	%	103.0
	12230816	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	104.0	CHEMBL4901	Homo sapiens	Residual Activity	%	104.0
	12230817	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	93.0	CHEMBL4901	Homo sapiens	Residual Activity	%	93.0
	12230818	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	125.0	CHEMBL4901	Homo sapiens	Residual Activity	%	125.0
	12230819	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	113.0	CHEMBL4901	Homo sapiens	Residual Activity	%	113.0
	12230820	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	110.0	CHEMBL4901	Homo sapiens	Residual Activity	%	110.0
	12230821	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	100.0	CHEMBL4901	Homo sapiens	Residual Activity	%	100.0
	12230822	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	120.0	CHEMBL4901	Homo sapiens	Residual Activity	%	120.0
	12230823	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	52.0	CHEMBL4901	Homo sapiens	Residual Activity	%	52.0
	12230824	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	109.0	CHEMBL4901	Homo sapiens	Residual Activity	%	109.0
	12230825	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	130.0	CHEMBL4901	Homo sapiens	Residual Activity	%	130.0
	12230826	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	90.0	CHEMBL4901	Homo sapiens	Residual Activity	%	90.0
	12230827	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	131.0	CHEMBL4901	Homo sapiens	Residual Activity	%	131.0
	12230828	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	106.0	CHEMBL4901	Homo sapiens	Residual Activity	%	106.0
	12230829	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	106.0	CHEMBL4901	Homo sapiens	Residual Activity	%	106.0
	12230830	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	83.0	CHEMBL4901	Homo sapiens	Residual Activity	%	83.0
	12230831	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	110.0	CHEMBL4901	Homo sapiens	Residual Activity	%	110.0
	12230832	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	94.0	CHEMBL4901	Homo sapiens	Residual Activity	%	94.0
	12230833	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	97.0	CHEMBL4901	Homo sapiens	Residual Activity	%	97.0
	12230834	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	80.0	CHEMBL4901	Homo sapiens	Residual Activity	%	80.0
	12230835	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	105.0	CHEMBL4901	Homo sapiens	Residual Activity	%	105.0
	12230836	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	121.0	CHEMBL4901	Homo sapiens	Residual Activity	%	121.0
	12230837	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	103.0	CHEMBL4901	Homo sapiens	Residual Activity	%	103.0
	12230838	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	101.0	CHEMBL4901	Homo sapiens	Residual Activity	%	101.0
	12230839	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	104.0	CHEMBL4901	Homo sapiens	Residual Activity	%	104.0
	12230840	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	87.0	CHEMBL4901	Homo sapiens	Residual Activity	%	87.0
	12230841	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	105.0	CHEMBL4901	Homo sapiens	Residual Activity	%	105.0
	12230842	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	103.0	CHEMBL4901	Homo sapiens	Residual Activity	%	103.0
	12230843	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	105.0	CHEMBL4901	Homo sapiens	Residual Activity	%	105.0
	12230844	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	84.0	CHEMBL4901	Homo sapiens	Residual Activity	%	84.0
	12230845	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	111.0	CHEMBL4901	Homo sapiens	Residual Activity	%	111.0
	12230846	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	99.0	CHEMBL4901	Homo sapiens	Residual Activity	%	99.0
	12230847	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	103.0	CHEMBL4901	Homo sapiens	Residual Activity	%	103.0
	12230848	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	97.0	CHEMBL4901	Homo sapiens	Residual Activity	%	97.0
	12230849	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	100.0	CHEMBL4901	Homo sapiens	Residual Activity	%	100.0
	12230850	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	112.0	CHEMBL4901	Homo sapiens	Residual Activity	%	112.0
	12230851	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	109.0	CHEMBL4901	Homo sapiens	Residual Activity	%	109.0
	12230852	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	113.0	CHEMBL4901	Homo sapiens	Residual Activity	%	113.0
	12230853	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	104.0	CHEMBL4901	Homo sapiens	Residual Activity	%	104.0
	12230854	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	95.0	CHEMBL4901	Homo sapiens	Residual Activity	%	95.0
	12230855	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	96.0	CHEMBL4901	Homo sapiens	Residual Activity	%	96.0
	12230856	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	107.0	CHEMBL4901	Homo sapiens	Residual Activity	%	107.0
	12230857	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	105.0	CHEMBL4901	Homo sapiens	Residual Activity	%	105.0
	12230858	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	82.0	CHEMBL4901	Homo sapiens	Residual Activity	%	82.0
	12230859	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	107.0	CHEMBL4901	Homo sapiens	Residual Activity	%	107.0
	12230860	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	108.0	CHEMBL4901	Homo sapiens	Residual Activity	%	108.0
	12230861	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	98.0	CHEMBL4901	Homo sapiens	Residual Activity	%	98.0
	12230862	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	94.0	CHEMBL4901	Homo sapiens	Residual Activity	%	94.0
	12230863	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	108.0	CHEMBL4901	Homo sapiens	Residual Activity	%	108.0
	12230864	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	117.0	CHEMBL4901	Homo sapiens	Residual Activity	%	117.0
	12230865	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	107.0	CHEMBL4901	Homo sapiens	Residual Activity	%	107.0
	12230866	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	105.0	CHEMBL4901	Homo sapiens	Residual Activity	%	105.0
	12230867	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	112.0	CHEMBL4901	Homo sapiens	Residual Activity	%	112.0
	12230868	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	107.0	CHEMBL4901	Homo sapiens	Residual Activity	%	107.0
	12230869	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	80.0	CHEMBL4901	Homo sapiens	Residual Activity	%	80.0
	12230870	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	101.0	CHEMBL4901	Homo sapiens	Residual Activity	%	101.0
	12230871	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	101.0	CHEMBL4901	Homo sapiens	Residual Activity	%	101.0
	12230872	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	112.0	CHEMBL4901	Homo sapiens	Residual Activity	%	112.0
	12230873	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	108.0	CHEMBL4901	Homo sapiens	Residual Activity	%	108.0
	12230874	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	104.0	CHEMBL4901	Homo sapiens	Residual Activity	%	104.0
	12230875	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	95.0	CHEMBL4901	Homo sapiens	Residual Activity	%	95.0
	12230876	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	109.0	CHEMBL4901	Homo sapiens	Residual Activity	%	109.0
	12230877	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	101.0	CHEMBL4901	Homo sapiens	Residual Activity	%	101.0
	12230878	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	107.0	CHEMBL4901	Homo sapiens	Residual Activity	%	107.0
	12230879	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	105.0	CHEMBL4901	Homo sapiens	Residual Activity	%	105.0
	12230880	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	81.0	CHEMBL4901	Homo sapiens	Residual Activity	%	81.0
	12230881	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	111.0	CHEMBL4901	Homo sapiens	Residual Activity	%	111.0
	12230882	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	90.0	CHEMBL4901	Homo sapiens	Residual Activity	%	90.0
	12230883	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	116.0	CHEMBL4901	Homo sapiens	Residual Activity	%	116.0
	12230884	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	112.0	CHEMBL4901	Homo sapiens	Residual Activity	%	112.0
	12230885	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	52.0	CHEMBL4901	Homo sapiens	Residual Activity	%	52.0
	12230886	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	95.0	CHEMBL4901	Homo sapiens	Residual Activity	%	95.0
	12230887	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	114.0	CHEMBL4901	Homo sapiens	Residual Activity	%	114.0
	12230888	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	109.0	CHEMBL4901	Homo sapiens	Residual Activity	%	109.0
	12230889	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	99.0	CHEMBL4901	Homo sapiens	Residual Activity	%	99.0
	12230890	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	110.0	CHEMBL4901	Homo sapiens	Residual Activity	%	110.0
	12230891	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	117.0	CHEMBL4901	Homo sapiens	Residual Activity	%	117.0
	12230892	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	98.0	CHEMBL4901	Homo sapiens	Residual Activity	%	98.0
	12230893	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	108.0	CHEMBL4901	Homo sapiens	Residual Activity	%	108.0
	12230894	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	107.0	CHEMBL4901	Homo sapiens	Residual Activity	%	107.0
	12230895	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	74.0	CHEMBL4901	Homo sapiens	Residual Activity	%	74.0
	12230896	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	107.0	CHEMBL4901	Homo sapiens	Residual Activity	%	107.0
	12230897	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	111.0	CHEMBL4901	Homo sapiens	Residual Activity	%	111.0
	12230898	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	111.0	CHEMBL4901	Homo sapiens	Residual Activity	%	111.0
	12230899	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	111.0	CHEMBL4901	Homo sapiens	Residual Activity	%	111.0
	12230900	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	105.0	CHEMBL4901	Homo sapiens	Residual Activity	%	105.0
	12230901	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	99.0	CHEMBL4901	Homo sapiens	Residual Activity	%	99.0
	12230902	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	112.0	CHEMBL4901	Homo sapiens	Residual Activity	%	112.0
	12230903	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	98.0	CHEMBL4901	Homo sapiens	Residual Activity	%	98.0
	12230904	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	117.0	CHEMBL4901	Homo sapiens	Residual Activity	%	117.0
	12230905	CHEMBL2219055	Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	112.0	CHEMBL4901	Homo sapiens	Residual Activity	%	112.0
	12649135	CHEMBL2329866	Displacement of ephrin-B1-Fc from EphB3 receptor Fc ectodomain (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2322989	=	IC50	nM	4400.0	CHEMBL4901	Homo sapiens	IC50	uM	4.4
	12674218	CHEMBL2344191	Inhibition of human Eph-B3 using [gamma-33P]ATP assessed as residual activity at 3 uM after 30 mins by radiometric assay	B	CCCCn1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333603	=	Activity	%	13.0	CHEMBL4901	Homo sapiens	Activity	%	13.0
	12728841	CHEMBL2352914	Inhibition of EPHB3 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	75.0	CHEMBL4901	Homo sapiens	Activity	%	75.0
	12729970	CHEMBL2352206	Inhibition of EPHB3 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	95.0	CHEMBL4901	Homo sapiens	Activity	%	95.0
	12729981	CHEMBL2352264	Inhibition of EPHB3 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	98.0	CHEMBL4901	Homo sapiens	Activity	%	98.0
	12730229	CHEMBL2352914	Inhibition of EPHB3 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	94.0	CHEMBL4901	Homo sapiens	Activity	%	94.0
Not Active	13360650	CHEMBL2400318	Inhibition of human EphB	B	COc1ccc2c(c1)C=C(C(=O)/C=C/c1c(OC)cc(OC)cc1OC)CO2		CHEMBL2396883		Inhibition	%		CHEMBL4901	Homo sapiens	INH		
	13375872	CHEMBL2405136	Inhibition of EPHB3 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	4.0	CHEMBL4901	Homo sapiens	INH	%	4.0
	13439852	CHEMBL2427153	Competitive binding affinity to EPHB3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
	13445385	CHEMBL2427153	Competitive binding affinity to EPHB3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
	13445685	CHEMBL2427153	Competitive binding affinity to EPHB3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
	13451672	CHEMBL2427153	Competitive binding affinity to EPHB3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
Active	13488400	CHEMBL2439414	Inhibition of human EPHB3 at 1 uM	B	Clc1ccc2ncc(Br)n2n1		CHEMBL2436439		Inhibition	%		CHEMBL4901	Homo sapiens	INH		
Not Active	13863488	CHEMBL3101977	Inhibition of EPHB3 (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(-c4ncccn4)c3)CC2)[C@H]1c1ccccc1		CHEMBL3099716		Inhibition	%		CHEMBL4901	Homo sapiens	INH		
Not Active	13863489	CHEMBL3101977	Inhibition of EPHB3 (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N(c2ccc(-c3cnc(N)c(-c4ncccn4)c3)cc2)[C@H]1c1ccccc1		CHEMBL3099720		Inhibition	%		CHEMBL4901	Homo sapiens	INH		
	13872153	CHEMBL3101778	Inhibition of human EphB3 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	123.0	CHEMBL4901	Homo sapiens	Activity	%	123.0
	14582492	CHEMBL3242344	Inhibition of human EphB3 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	91.5	CHEMBL4901	Homo sapiens	Activity	%	91.5
	14664161	CHEMBL3270869	Inhibition of EPHB3 (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	71.0	CHEMBL4901	Homo sapiens	INH	%	71.0
	14664162	CHEMBL3270869	Inhibition of EPHB3 (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	86.0	CHEMBL4901	Homo sapiens	INH	%	86.0
	14664163	CHEMBL3270869	Inhibition of EPHB3 (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	97.0	CHEMBL4901	Homo sapiens	INH	%	97.0
	15018584	CHEMBL3362248	Inhibition of EPHB3 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	2.9	CHEMBL4901	Homo sapiens	INH	%	2.9
	15072604	CHEMBL3382664	Inhibition of EPHB3 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	109.0	CHEMBL4901	Homo sapiens	Activity	%	109.0
	15251821	CHEMBL3428399	Inhibition of EPH-B3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	38.0	CHEMBL4901	Homo sapiens	Activity	%	38.0
	15251976	CHEMBL3428399	Inhibition of EPH-B3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	46.0	CHEMBL4901	Homo sapiens	Activity	%	46.0
	15252078	CHEMBL3428399	Inhibition of EPH-B3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	88.0	CHEMBL4901	Homo sapiens	Activity	%	88.0
	15252723	CHEMBL3428399	Inhibition of EPH-B3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	93.0	CHEMBL4901	Homo sapiens	Activity	%	93.0
	15252825	CHEMBL3428399	Inhibition of EPH-B3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	79.0	CHEMBL4901	Homo sapiens	Activity	%	79.0
	15253499	CHEMBL3428399	Inhibition of EPH-B3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	83.0	CHEMBL4901	Homo sapiens	Activity	%	83.0
	15253601	CHEMBL3428399	Inhibition of EPH-B3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	110.0	CHEMBL4901	Homo sapiens	Activity	%	110.0
	15253703	CHEMBL3428399	Inhibition of EPH-B3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	106.0	CHEMBL4901	Homo sapiens	Activity	%	106.0
	15254369	CHEMBL3428399	Inhibition of EPH-B3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	110.0	CHEMBL4901	Homo sapiens	Activity	%	110.0
	15254471	CHEMBL3428399	Inhibition of EPH-B3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	85.0	CHEMBL4901	Homo sapiens	Activity	%	85.0
	15254573	CHEMBL3428399	Inhibition of EPH-B3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	99.0	CHEMBL4901	Homo sapiens	Activity	%	99.0
	15255263	CHEMBL3428399	Inhibition of EPH-B3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	87.0	CHEMBL4901	Homo sapiens	Activity	%	87.0
	15255366	CHEMBL3428399	Inhibition of EPH-B3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	110.0	CHEMBL4901	Homo sapiens	Activity	%	110.0
	15255468	CHEMBL3428399	Inhibition of EPH-B3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	101.0	CHEMBL4901	Homo sapiens	Activity	%	101.0
	15256200	CHEMBL3428399	Inhibition of EPH-B3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	84.0	CHEMBL4901	Homo sapiens	Activity	%	84.0
	15256302	CHEMBL3428399	Inhibition of EPH-B3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	79.0	CHEMBL4901	Homo sapiens	Activity	%	79.0
	15756998	CHEMBL3630485	Inhibition of EPHB3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	93.28	CHEMBL4901	Homo sapiens	INH	%	93.28
	15757725	CHEMBL3630485	Inhibition of EPHB3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	7.1	CHEMBL4901	Homo sapiens	INH	%	7.1
	15758704	CHEMBL3630485	Inhibition of EPHB3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	5.87	CHEMBL4901	Homo sapiens	INH	%	5.87
Dose-dependent effect	16392482	CHEMBL3738311	Displacement of biotinylated ephrin-B1-Fc from EphB3 (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-B1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863		Inhibition	%		CHEMBL4901	Homo sapiens	INH		
	16392521	CHEMBL3738311	Displacement of biotinylated ephrin-B1-Fc from EphB3 (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-B1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863	=	IC50	nM	3900.0	CHEMBL4901	Homo sapiens	IC50	uM	3.9
	16425307	CHEMBL3751077	Inhibition of EphB3 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	2.5	CHEMBL4901	Homo sapiens	INH	%	2.5
	16431821	CHEMBL3748175	Inhibition of human EPHB3 using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4901	Homo sapiens	IC50	uM	10.0
	16450835	CHEMBL3762691	Inhibition of EPHB3 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	20.1	CHEMBL4901	Homo sapiens	INH	%	20.1
Active	16494484	CHEMBL3772795	Induction of EPHB3 phosphorylation in human T47D cells at 2.5 uM after 24 hrs by phospho-RTK array analysis	B	C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H](OC(=O)[C@H]5CCCN5)CC[C@@]43C)[C@@H]1Cc1snnc12		CHEMBL3769913		Activity			CHEMBL4901	Homo sapiens	Activity		
	16495985	CHEMBL3778576	Inhibition of N-terminal His6-tagged recombinant human EPHB3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-6.0	CHEMBL4901	Homo sapiens	Activity	%	-6.0
	16508172	CHEMBL3778576	Inhibition of N-terminal His6-tagged recombinant human EPHB3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	15.0	CHEMBL4901	Homo sapiens	Activity	%	15.0
	16509149	CHEMBL3778576	Inhibition of N-terminal His6-tagged recombinant human EPHB3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-3.0	CHEMBL4901	Homo sapiens	Activity	%	-3.0
	16578359	CHEMBL3804618	Inhibition of partial length wild type human EPHB3 expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	94.0	CHEMBL4901	Homo sapiens	Activity	%	94.0
	16611853	CHEMBL3816751	Inhibition of human EPHB3 (561 to 998 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-25.0	CHEMBL4901	Homo sapiens	Activity	%	-25.0
	16611854	CHEMBL3816751	Inhibition of human EPHB3 (561 to 998 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-19.0	CHEMBL4901	Homo sapiens	Activity	%	-19.0
	16611855	CHEMBL3816751	Inhibition of human EPHB3 (561 to 998 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	28.0	CHEMBL4901	Homo sapiens	Activity	%	28.0
	16614466	CHEMBL3816596	Inhibition of human EPHB3 at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	7.0	CHEMBL4901	Homo sapiens	INH	%	7.0
	16618226	CHEMBL3816229	Inhibition of recombinant human GST-tagged cytoplasmic EPHB3 (623 to 907 residues) expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
	16628524	CHEMBL3820640	Inhibition of EPHB3 (unknown origin) at 1 uM	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	<	Inhibition	%	80.0	CHEMBL4901	Homo sapiens	INH	%	80.0
	16654252	CHEMBL3829898	Inhibition of human EPHB3 (561 to 998 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	82.0	CHEMBL4901	Homo sapiens	Activity	%	82.0
Inactive	17900553	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900554	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900555	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900556	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Active	17900557	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	2652.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	2652.0
Inactive	17900558	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900559	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900560	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900561	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900562	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Active	17900563	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	547.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	547.0
Inactive	17900564	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900565	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900566	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900567	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900568	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900569	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900570	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900571	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900572	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900573	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900574	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Active	17900575	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	Kd	nM	2.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	2.0
Inactive	17900576	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900577	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900578	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900579	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900580	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Active	17900581	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	29.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	29.0
Inactive	17900582	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900583	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900584	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900585	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900586	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Active	17900587	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Kd	nM	5433.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	5433.0
Inactive	17900588	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900589	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900590	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900591	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900592	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900593	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900594	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900595	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900596	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900597	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900598	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900599	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900600	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900601	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900602	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900603	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900604	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900605	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900606	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Active	17900607	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	2349.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	2349.0
Inactive	17900608	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900609	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900610	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900611	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900612	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900613	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900614	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900615	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900616	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900617	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900618	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900619	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900620	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900621	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900622	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900623	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900624	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900625	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900626	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900627	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900628	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900629	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900630	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900631	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900632	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900633	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900634	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900635	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900636	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900637	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900638	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900639	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900640	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900641	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900642	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Active	17900643	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	=	Kd	nM	4824.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	4824.0
Inactive	17900644	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900645	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900646	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900647	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900648	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900649	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900650	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900651	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900652	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900653	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900654	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900655	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900656	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900657	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900658	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900659	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900660	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900661	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900662	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900663	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900664	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Active	17900665	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	1529.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	1529.0
Inactive	17900666	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900667	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900668	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Active	17900669	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	=	Kd	nM	5500.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	5500.0
Inactive	17900670	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900671	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900672	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900673	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900674	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900675	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900676	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900677	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Active	17900678	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	175.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	175.0
Inactive	17900679	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900680	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900681	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900682	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900683	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900684	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900685	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900686	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900687	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900688	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900689	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900690	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900691	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900692	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900693	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900694	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900695	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900696	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900697	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900698	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900699	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900700	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900701	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900702	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900703	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Active	17900704	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	4546.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	4546.0
Inactive	17900705	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900706	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900707	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900708	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900709	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900710	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17900711	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	=	Kd	nM	28160.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	28160.0
Inactive	17900712	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900713	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900714	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900715	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900716	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900717	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900718	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900719	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900720	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900721	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900722	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900723	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900724	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900725	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900726	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900727	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900728	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900729	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900730	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900731	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900732	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900733	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900734	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900735	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900736	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900737	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900738	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900739	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Active	17900740	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	2598.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	2598.0
Inactive	17900741	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900742	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900743	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900744	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900745	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900746	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900747	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900748	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900749	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900750	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900751	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900752	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900753	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900754	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900755	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900756	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900757	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900758	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900759	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900760	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900761	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900762	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900763	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900764	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900765	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900766	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900767	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900768	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900769	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900770	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900771	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900772	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900773	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900774	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900775	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900776	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900777	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900778	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900779	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900780	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900781	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900782	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900783	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900784	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900785	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900786	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900787	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900788	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900789	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900790	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900791	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900792	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900793	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900794	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	30000.0
Active	17900795	CHEMBL3991706	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	6410.0	CHEMBL4901	Homo sapiens	Kd apparent	nM	6410.0
	18053075	CHEMBL4011855	Inhibition of EPHB3 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	1.5	CHEMBL4901	Homo sapiens	INH	%	1.5
	18114371	CHEMBL4025123	Inhibition of wild-type human partial length EPHB3 (Q599 to T928 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	92.0	CHEMBL4901	Homo sapiens	Activity	%	92.0
	18203647	CHEMBL4043934	Inhibition of wild-type human partial length EPHB3 (Q599 to T928 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL4901	Homo sapiens	Activity	%	100.0
	18232193	CHEMBL4050313	Inhibition of human EPHB3 assessed as residual activity at 1 uM in presence of 33P-ATP by filter-binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	56.0	CHEMBL4901	Homo sapiens	Activity	%	56.0
	18253803	CHEMBL4055186	Inhibition of wild-type human partial length EPHB3 (Q599 to T928 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL4901	Homo sapiens	Activity	%	100.0
	18253804	CHEMBL4055186	Inhibition of wild-type human partial length EPHB3 (Q599 to T928 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL4901	Homo sapiens	Activity	%	100.0
	18265783	CHEMBL4057233	Inhibition of EPHB3 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	2.7	CHEMBL4901	Homo sapiens	INH	%	2.7
	18265981	CHEMBL4057431	Inhibition of EPHB3 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	0.7	CHEMBL4901	Homo sapiens	INH	%	0.7
	18282103	CHEMBL4120058	Inhibition of recombinant GST-tagged human EphB3 cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	4.6	CHEMBL4901	Homo sapiens	INH	%	4.6
	18282422	CHEMBL4120058	Inhibition of recombinant GST-tagged human EphB3 cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	10.0	CHEMBL4901	Homo sapiens	INH	%	10.0
	18282752	CHEMBL4120337	Inhibition of EPHB3 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	2.7	CHEMBL4901	Homo sapiens	INH	%	2.7
	18282979	CHEMBL4120564	Inhibition of EPHB3 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	1.0	CHEMBL4901	Homo sapiens	INH	%	1.0
	18283203	CHEMBL4120788	Inhibition of EPHB3 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	0.7	CHEMBL4901	Homo sapiens	INH	%	0.7
	18440189	CHEMBL4157013	Binding affinity to wild-type human partial length EPHB3 (Q599 to T928 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	96.0	CHEMBL4901	Homo sapiens	Activity	%	96.0
	18449921	CHEMBL4178155	Inhibition of human EPHB3 (565 to 984 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	89.0	CHEMBL4901	Homo sapiens	Activity	%	89.0
	18484629	CHEMBL4185792	Binding affinity to wild-type human partial length EPHB3 (Q599 to T928 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	88.0	CHEMBL4901	Homo sapiens	Activity	%	88.0
	18484992	CHEMBL4185792	Binding affinity to wild-type human partial length EPHB3 (Q599 to T928 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	89.0	CHEMBL4901	Homo sapiens	Activity	%	89.0
	18507799	CHEMBL4190963	Inhibition of recombinant human EPHB3 (599 to 920 residues) at 1 uM using poly(Glu,Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-2.0	CHEMBL4901	Homo sapiens	INH	%	-2.0
	18653651	CHEMBL4230078	Inhibition of EPH-B3 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	98.0	CHEMBL4901	Homo sapiens	INH	%	98.0
	18653652	CHEMBL4230078	Inhibition of EPH-B3 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	86.0	CHEMBL4901	Homo sapiens	INH	%	86.0
	18655543	CHEMBL4230692	Binding affinity to wild-type human partial length EPHB3 (Q599 to T928 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	94.0	CHEMBL4901	Homo sapiens	Activity	%	94.0
	18751118	CHEMBL4263796	Inhibition of EPH-B3 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	-3.0	CHEMBL4901	Homo sapiens	INH	%	-3.0
	18751622	CHEMBL4264281	Binding affinity to wild-type human partial length EPHB3 (Q599 to T928 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL4901	Homo sapiens	Activity	%	100.0
	18764617	CHEMBL4267108	Inhibition of human EPHB3 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL4901	Homo sapiens	INH	%	70.0
	18764618	CHEMBL4267108	Inhibition of human EPHB3 at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL4901	Homo sapiens	INH	%	70.0
	18764619	CHEMBL4267108	Inhibition of human EPHB3 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL4901	Homo sapiens	INH	%	70.0
	18857950	CHEMBL4307796	Binding affinity to wild-type human partial length EPHB3 (Q599 to T928 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	99.0	CHEMBL4901	Homo sapiens	Activity	%	99.0
	18892608	CHEMBL4314693	Inhibition of recombinant human EphB3 (599 to 920 residues) assessed as residual activity at 10 uM using poly (Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	110.0	CHEMBL4901	Homo sapiens	Activity	%	110.0
	18937903	CHEMBL4327682	Inhibition of human EPHB3 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	93.04	CHEMBL4901	Homo sapiens	Activity	%	93.04
	18937904	CHEMBL4327682	Inhibition of human EPHB3 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	93.99	CHEMBL4901	Homo sapiens	Activity	%	93.99
	18938522	CHEMBL4328042	Inhibition of human EPHB3 assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4901	Homo sapiens	Activity	%	65.0
	18938900	CHEMBL4328406	Inhibition of human EPHB3 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1830.0	CHEMBL4901	Homo sapiens	IC50	10'-6M	1.83
	18953699	CHEMBL4331918	Inhibition of EPHB3 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(NC3CCCCC3)c12		CHEMBL4440433	=	Inhibition	%	39.0	CHEMBL4901	Homo sapiens	INH	%	39.0
	18953765	CHEMBL4331918	Inhibition of EPHB3 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccccc3F)c12		CHEMBL4449552	=	Inhibition	%	39.0	CHEMBL4901	Homo sapiens	INH	%	39.0
	18953832	CHEMBL4331918	Inhibition of EPHB3 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(OC3CCCCC3)c12		CHEMBL4524629	=	Inhibition	%	92.0	CHEMBL4901	Homo sapiens	INH	%	92.0
	18953924	CHEMBL4331977	Inhibition of EPHB3 (unknown origin) at 1 uM relative to control	B	CC(C)n1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cn1		CHEMBL4589022	=	Inhibition	%	0.0	CHEMBL4901	Homo sapiens	INH	%	0.0
	18953988	CHEMBL4331977	Inhibition of EPHB3 (unknown origin) at 1 uM relative to control	B	c1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cc(N2CCOCC2)n1		CHEMBL4460272	=	Inhibition	%	0.0	CHEMBL4901	Homo sapiens	INH	%	0.0
	18954055	CHEMBL4331918	Inhibition of EPHB3 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccc4ncsc4c3)c12		CHEMBL4588446	=	Inhibition	%	68.0	CHEMBL4901	Homo sapiens	INH	%	68.0
	18954147	CHEMBL4332030	Inhibition of human EPHB3 (599 to 920 residues) using poly (Glu, Tyr) 4:1 as substrate at 1 uM after 40 mins in presence of [gamma-33P]-ATP by scintillation counting relative to control	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670	=	Inhibition	%	58.0	CHEMBL4901	Homo sapiens	INH	%	58.0
	18958867	CHEMBL4333386	Binding affinity to wild-type human partial length EPHB3 (Q599 to T928 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	94.0	CHEMBL4901	Homo sapiens	Activity	%	94.0
	18964275	CHEMBL4335075	Inhibition of recombinant human EphB3 (599 to 920 residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	106.0	CHEMBL4901	Homo sapiens	Activity	%	106.0
	18964276	CHEMBL4335075	Inhibition of recombinant human EphB3 (599 to 920 residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	104.0	CHEMBL4901	Homo sapiens	Activity	%	104.0
	18971892	CHEMBL4336902	Inhibition of recombinant human EphB3 (599 to 920 residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	123.0	CHEMBL4901	Homo sapiens	Activity	%	123.0
Not Active	19039789	CHEMBL4351853	Inhibition of recombinant human EphB3 (599 to 920 residues) at 10 uM using poly (Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4901	Homo sapiens	INH		
Active	19041100	CHEMBL4352361	Inhibition of human EPHB3 at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4901	Homo sapiens	INH		
	19059569	CHEMBL4357870	Binding affinity to wild-type human partial length EPHB3 (Q599 to T928 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	97.0	CHEMBL4901	Homo sapiens	Activity	%	97.0
	19090140	CHEMBL4365714	Inhibition of wild-type human partial length EPHB3 (Q599 to T928 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	97.0	CHEMBL4901	Homo sapiens	Activity	%	97.0
	19091915	CHEMBL4366389	Inhibition of human EPHB3 at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-1.65	CHEMBL4901	Homo sapiens	INH	%	-1.65
	19144791	CHEMBL4377807	Inhibition of recombinant human EphB3 (599 to 920 residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	12.0	CHEMBL4901	Homo sapiens	INH	%	12.0
	19147843	CHEMBL4379317	Inhibition of recombinant human EphB3 (599 to 920 residues) using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4901	Homo sapiens	IC50	uM	10.0
	19159397	CHEMBL4382501	Binding affinity to wild-type human partial length EPHB3 (Q599 to T928 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	63.0	CHEMBL4901	Homo sapiens	Activity	%	63.0
	19181026	CHEMBL4387237	Inhibition of recombinant human GST-tagged EPHB3 catalytic domain (623 to 907 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	-0.5	CHEMBL4901	Homo sapiens	INH	%	-0.5
	19181252	CHEMBL4387237	Inhibition of recombinant human GST-tagged EPHB3 catalytic domain (623 to 907 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	1.0	CHEMBL4901	Homo sapiens	INH	%	1.0
	19191610	CHEMBL4389220	Inhibition of wild-type human partial length EPHB3 (Q599 to T928 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL4901	Homo sapiens	INH	%	100.0
	19191883	CHEMBL4389697	Inhibition of wild-type human partial length EPHB3 (Q599 to T928 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL4901	Homo sapiens	INH	%	100.0
	19199899	CHEMBL4391323	Binding affinity to wild-type human partial length EPHB3 (Q599 to T928 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	100.0	CHEMBL4901	Homo sapiens	Activity	%	100.0
	19266411	CHEMBL4405361	Inhibition of wild-type human partial length EPHB3 (Q599 to T928 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4901	Homo sapiens	INH	%	50.0
	19275990	CHEMBL4407993	Inhibition of recombinant human EPhB3 (599 to 920 residues) at 1 uM using poly (Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	2.0	CHEMBL4901	Homo sapiens	INH	%	2.0
	20600522	CHEMBL4603474	Inhibition of recombinant human GST-tagged EPHB3 catalytic domain expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL4901	Homo sapiens	IC50	uM	100.0
	20608953	CHEMBL4605666	Inhibition of EPHB3 (unknown origin) assessed as residual activity incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCC4C=NNC4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4640297	=	IC50	nM	50.5	CHEMBL4901	Homo sapiens	IC50	uM	0.0505
	20608964	CHEMBL4605655	Inhibition of EPHB3 (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3CCC4C=NNC4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4640297	=	Activity	%	6.0	CHEMBL4901	Homo sapiens	Activity	%	6.0
	20609003	CHEMBL4605655	Inhibition of EPHB3 (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3Cc4cn[nH]c4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4638981	=	Activity	%	5.0	CHEMBL4901	Homo sapiens	Activity	%	5.0
	20609014	CHEMBL4605666	Inhibition of EPHB3 (unknown origin) assessed as residual activity incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	Cc1ccc(C(=O)Nc2ccc(CN3Cc4cn[nH]c4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4638981	=	IC50	nM	19.5	CHEMBL4901	Homo sapiens	IC50	uM	0.0195
	20609035	CHEMBL4605655	Inhibition of EPHB3 (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Activity	%	52.0	CHEMBL4901	Homo sapiens	Activity	%	52.0
	20609051	CHEMBL4605655	Inhibition of EPHB3 (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Activity	%	1.0	CHEMBL4901	Homo sapiens	Activity	%	1.0
	22392050	CHEMBL4667145	Inhibition of recombinant human GST-tagged EPHB3 (623 to 907 residues) expressed in baculovirus expression system using Tyr 02 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	1.0	CHEMBL4901	Homo sapiens	INH	%	1.0
	22423639	CHEMBL4674395	Inhibition of human EPHB3 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	98.37	CHEMBL4901	Homo sapiens	Activity	%	98.37
	22423640	CHEMBL4674395	Inhibition of human EPHB3 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	100.0	CHEMBL4901	Homo sapiens	Activity	%	100.0
	22843757	CHEMBL4720743	Inhibition of human EPHB3 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	741.0	CHEMBL4901	Homo sapiens	IC50	10^-7M	7.41
	22844110	CHEMBL4721096	Inhibition of human EPHB3 assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	99.84	CHEMBL4901	Homo sapiens	Activity	%	99.84
	22844699	CHEMBL4721374	Inhibition of wild-type human partial length EPHB3 (Q599 to T928 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	94.43	CHEMBL4901	Homo sapiens	Activity	%	94.43
	22952831	CHEMBL4766768	Inhibition of recombinant human EphB3 (599 to 920 residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	41.0	CHEMBL4901	Homo sapiens	Activity	%	41.0
	23122555	CHEMBL4804906	Inhibition of human EPHB3 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	81.0	CHEMBL4901	Homo sapiens	Activity	%	81.0
	23123250	CHEMBL4805494	Inhibition of human EPHB3 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL4901	Homo sapiens	Activity	%	100.0
	23123641	CHEMBL4805885	Inhibition of DNA-tagged human EPHB3 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	90.0	CHEMBL4901	Homo sapiens	Activity	%	90.0
	23124590	CHEMBL4806511	Inhibition of human EPHB3 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	96.0	CHEMBL4901	Homo sapiens	Activity	%	96.0
	23124591	CHEMBL4806511	Inhibition of human EPHB3 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	94.0	CHEMBL4901	Homo sapiens	Activity	%	94.0
	23127421	CHEMBL4807601	Inhibition of EPHB3 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	3.0	CHEMBL4901	Homo sapiens	Activity	%	3.0
	23127422	CHEMBL4807601	Inhibition of EPHB3 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	1.0	CHEMBL4901	Homo sapiens	Activity	%	1.0
	23128071	CHEMBL4807832	Inhibition of EPHB3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL4901	Homo sapiens	Activity	%	25.0
	23128072	CHEMBL4807832	Inhibition of EPHB3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	<	Activity	%	25.0	CHEMBL4901	Homo sapiens	Activity	%	25.0
	23128073	CHEMBL4807832	Inhibition of EPHB3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL4901	Homo sapiens	Activity	%	25.0
	23128919	CHEMBL4808095	Inhibition of EPHB3 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(C(F)(F)F)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4870763	=	Inhibition	%	23.0	CHEMBL4901	Homo sapiens	INH	%	23.0
Not Active	23317390	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	75.0	CHEMBL4901	Homo sapiens	% Control	%	75.0
Not Active	23317858	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	96.0	CHEMBL4901	Homo sapiens	% Control	%	96.0
Not Active	23318527	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Active	23319008	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	6.0	CHEMBL4901	Homo sapiens	% Control	%	6.0
Not Active	23319645	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23320120	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23320798	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23321266	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	93.0	CHEMBL4901	Homo sapiens	% Control	%	93.0
Not Active	23321896	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	97.0	CHEMBL4901	Homo sapiens	% Control	%	97.0
Not Active	23322364	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	96.0	CHEMBL4901	Homo sapiens	% Control	%	96.0
Not Active	23323053	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	90.0	CHEMBL4901	Homo sapiens	% Control	%	90.0
Not Active	23323521	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	91.0	CHEMBL4901	Homo sapiens	% Control	%	91.0
Not Active	23324003	CHEMBL4880622	EphB3 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	-5.0	CHEMBL4901	Homo sapiens	% inhibition	%	-5.0
Not Active	23324375	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23325010	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	89.0	CHEMBL4901	Homo sapiens	% Control	%	89.0
Not Active	23325478	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23326125	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	94.0	CHEMBL4901	Homo sapiens	% Control	%	94.0
Not Active	23326593	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	62.0	CHEMBL4901	Homo sapiens	% Control	%	62.0
Not Active	23327293	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23327761	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23328348	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	96.0	CHEMBL4901	Homo sapiens	% Control	%	96.0
Not Active	23328816	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23329336	CHEMBL4881043	EphB3(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	42.0	CHEMBL4901	Homo sapiens	% residual kinase activity	%	42.0
Not Active	23329762	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23330230	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23330986	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23331454	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23332041	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23332507	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23333225	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23333864	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23334332	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23335311	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23335779	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23336406	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	81.0	CHEMBL4901	Homo sapiens	% Control	%	81.0
Not Active	23336874	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23337588	CHEMBL4881959	EPHB3 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	97.0	CHEMBL4901	Homo sapiens	% Ctrl	%	97.0
Not Active	23337955	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23338423	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	95.0	CHEMBL4901	Homo sapiens	% Control	%	95.0
Not Active	23339035	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23339503	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	92.0	CHEMBL4901	Homo sapiens	% Control	%	92.0
Not Active	23340140	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23340608	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23341265	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	97.0	CHEMBL4901	Homo sapiens	% Control	%	97.0
Not Active	23341733	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	93.0	CHEMBL4901	Homo sapiens	% Control	%	93.0
Not Active	23342349	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	76.0	CHEMBL4901	Homo sapiens	% Control	%	76.0
Not Active	23342817	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23343447	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	90.0	CHEMBL4901	Homo sapiens	% Control	%	90.0
Not Active	23343915	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23344553	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	89.0	CHEMBL4901	Homo sapiens	% Control	%	89.0
Not Active	23345126	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23345594	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23346171	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23346640	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23347248	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	94.8	CHEMBL4901	Homo sapiens	% Control	%	94.8
Not Active	23347731	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23348310	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23348778	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23349365	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23349983	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23350451	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23351056	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	88.0	CHEMBL4901	Homo sapiens	% Control	%	88.0
Not Active	23351524	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	90.0	CHEMBL4901	Homo sapiens	% Control	%	90.0
Not Active	23352039	CHEMBL4882730	EPHB3 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	9.869	CHEMBL4901	Homo sapiens	% Inhibition	%	9.8686
Not Active	23352548	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	98.0	CHEMBL4901	Homo sapiens	% Control	%	98.0
Not Active	23353016	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23353898	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23354366	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23355098	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23355566	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23356202	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23356670	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23357279	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23357926	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	81.0	CHEMBL4901	Homo sapiens	% Control	%	81.0
Not Active	23358394	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23358980	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	85.4	CHEMBL4901	Homo sapiens	% Control	%	85.4
Not Active	23359578	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	78.0	CHEMBL4901	Homo sapiens	% Control	%	78.0
Not Active	23360046	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	85.0	CHEMBL4901	Homo sapiens	% Control	%	85.0
Not Active	23360631	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	95.0	CHEMBL4901	Homo sapiens	% Control	%	95.0
Not Active	23361099	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23361672	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23362208	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23362676	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23364318	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	94.0	CHEMBL4901	Homo sapiens	% Control	%	94.0
Not Active	23364786	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23365525	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23366068	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	97.0	CHEMBL4901	Homo sapiens	% Control	%	97.0
Not Active	23366658	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	96.0	CHEMBL4901	Homo sapiens	% Control	%	96.0
Not Active	23367126	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	79.0	CHEMBL4901	Homo sapiens	% Control	%	79.0
Not Active	23367561	CHEMBL4883914	EPHB3 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	108.0	CHEMBL4901	Homo sapiens	% Residual activity with Skepinone-L	%	108.0
Not Active	23368004	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23368472	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23369071	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	93.0	CHEMBL4901	Homo sapiens	% Control	%	93.0
Not Active	23369539	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23370058	CHEMBL4884302	EphB3(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	109.0	CHEMBL4901	Homo sapiens	% residual kinase activity	%	109.0
Not Active	23370507	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	57.0	CHEMBL4901	Homo sapiens	% Control	%	57.0
Not Active	23370975	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	99.0	CHEMBL4901	Homo sapiens	% Control	%	99.0
Not Active	23371784	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	87.0	CHEMBL4901	Homo sapiens	% Control	%	87.0
Not Active	23372252	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	91.0	CHEMBL4901	Homo sapiens	% Control	%	91.0
	23372739	CHEMBL4884704	EphB3(EPB3LGRJ) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4901	Homo sapiens	pIC50		6.0
	23373148	CHEMBL4884995	EphB3(EPB3LGRJ) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4901	Homo sapiens	pIC50		6.0
	23373509	CHEMBL4885286	EphB3(EPB3LGRJ) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4901	Homo sapiens	pIC50		6.0
Not Active	23374973	CHEMBL4885967	EphB3 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	0.0	CHEMBL4901	Homo sapiens	% Inhibition	%	0.0
Not Active	23375243	CHEMBL4886225	EPH receptor B3 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	3.0	CHEMBL4901	Homo sapiens	% inhibition	%	3.0
Not Active	23375679	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	88.0	CHEMBL4901	Homo sapiens	% Control	%	88.0
Not Active	23376147	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23376724	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23377193	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	80.0	CHEMBL4901	Homo sapiens	% Control	%	80.0
Not Active	23378052	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	80.0	CHEMBL4901	Homo sapiens	% Control	%	80.0
Not Active	23378520	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	86.0	CHEMBL4901	Homo sapiens	% Control	%	86.0
Not Active	23379687	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	92.0	CHEMBL4901	Homo sapiens	% Control	%	92.0
Not Active	23380155	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	90.0	CHEMBL4901	Homo sapiens	% Control	%	90.0
Not Active	23380849	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	99.0	CHEMBL4901	Homo sapiens	% Control	%	99.0
Not Active	23381497	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23381965	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	99.0	CHEMBL4901	Homo sapiens	% Control	%	99.0
Not Active	23382589	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	87.0	CHEMBL4901	Homo sapiens	% Control	%	87.0
Not Active	23383057	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	95.0	CHEMBL4901	Homo sapiens	% Control	%	95.0
Not Active	23383782	CHEMBL4887421	EPHB3 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	99.0	CHEMBL4901	Homo sapiens	% Ctrl	%	99.0
Not Active	23384267	CHEMBL4887862	EphB3(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	-5.61	CHEMBL4901	Homo sapiens	% inhibition	%	-5.61
Not Active	23384972	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
Not Active	23385439	CHEMBL4879696	KinomeScan assay: inhibition of EPHB3	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL4901	Homo sapiens	% Control	%	100.0
